"Management's Discussion and Analysis of Financial Condition and Results of
Operations" is based on our consolidated financial statements, which have been
prepared in accordance with U.S. GAAP. The preparation of these financial
statements requires us to make estimates and assumptions that affect the
reported amounts of assets, liabilities, revenues and expenses, and related
disclosures of contingent assets and liabilities. On a regular basis, we
evaluate these estimates, including fair value of financial instruments. These
estimates are based on historical experience and on various other assumptions
that are believed to be reasonable under the circumstances. Actual results may
differ from these estimates.


All amounts in this disclosure are in thousands (except share, unit, per share, and per unit data) except where otherwise noted.





Overview



We are a financial services company specializing in fixed income markets and,
more recently, the SPAC markets. We were founded in 1999 as an investment firm
focused on small-cap banking institutions but have grown to provide an expanding
range of capital markets and asset management services. We are organized into
three business segments: Capital Markets, Asset Management, and Principal
Investing.



• Capital Markets: Our Capital Markets business segment consists primarily of

fixed income sales, trading, matched book repo financing, new issue placements

in corporate and securitized products, and advisory services. Our fixed income

sales and trading group provides trade execution to corporate investors,

institutional investors, mortgage originators, and other smaller

broker-dealers. We specialize in a variety of products, including but not

limited to: corporate bonds, ABS, MBS, RMBS, CDOs, CLOs, CBOs, CMOs, municipal

securities, TBAs and other forward agency MBS contracts, SBA loans, U.S.

government bonds, U.S. government agency securities, brokered deposits and CDs

for small banks, and hybrid capital of financial institutions including TruPS,

whole loans, and other structured financial instruments. We also offer

execution and brokerage services for equity products. We carry out our capital

markets activities primarily through our subsidiaries: JVB in the U.S. and

CCFEL in Europe.

• Asset Management: Our Asset Management business segment manages assets within

CDOs, managed accounts, joint ventures, and investment funds (collectively,

"Investment Vehicles"). A CDO is a form of secured borrowing. The borrowing is

secured by different types of fixed income assets such as corporate or

mortgage loans or bonds. The borrowing is in the form of a securitization,

which means that the lenders are actually investing in notes backed by the

assets. In the event of default, the lenders will have recourse only to the

assets securing the loan. Our Asset Management business segment includes our

fee-based asset management operations, which include on-going base and

incentive management fees. As of December 31, 2020, we had approximately

$2.77 billion in AUM, $2.06 billion of which was in CDOs. A substantial

portion of our asset management revenue is earned from the management of

CDOs. We have not completed a new securitization since 2008. As a result, our

asset management revenue has declined from its historical highs as the assets

of the CDOs decline due to maturities, repayments, auction call redemptions,

and defaults. Our ability to complete securitizations in the future will

depend upon, among other things, our asset origination capacity and success,

our ability to arrange warehouse financing to originate assets, our

willingness and capacity to fund required amounts to obtain warehouse

financing and securitized financings, and the demand in the markets for such

securitizations. The remaining portion of our AUM is from a diversified mix of

other Investment Vehicles that were more recently formed.

• Principal Investing: Our Principal Investing business segment is comprised of

investments that we hold related to our SPAC franchise and other investments

we have made for the purpose of earning an investment return rather than

investments made to support our trading, matched book repo, or other Capital

Markets business segment activities. These investments are included in other

investments, at fair value and investments in equity method affiliates in


    our consolidated balance sheets.



We generate our revenue by business segment primarily through the following activities.





Capital Markets:



• Our trading activities, which include execution and brokerage services,

securities lending activities, riskless trading activities, as well as gains

and losses (unrealized and realized) and income and expense earned on

securities classified as trading;

• Net interest income on our matched book repo financing activities; and

• New issue and advisory revenue comprised of (a) new issue revenue associated

with originating, arranging, or placing newly created financial instruments;


    and (b) revenue from advisory services.




Asset Management:



• Asset management fees for our on-going asset management services provided to

certain Investment Vehicles, which may include fees both senior and

subordinate to the securities issued by the Investment Vehicle; and

• Incentive management fees earned based on the performance of the certain


     Investment Vehicles.




Principal Investing:



• Gains and losses (unrealized and realized) and income and expense earned on


    securities classified as other investments, at fair value; and
  • Income and loss earned on equity method investments.




                                       38

--------------------------------------------------------------------------------





Business Environment



Our business in general and our Capital Markets business segment in particular,
do not produce predictable earnings. Our results can vary dramatically from year
to year and quarter to quarter.



Our business is materially affected by economic conditions in the financial
markets, political conditions, broad trends in business and finance, the housing
and mortgage markets, changes in volume and price levels of securities
transactions, and changes in interest rates, including overnight funding rates,
all of which can affect our profitability and are unpredictable and beyond our
control. These factors may affect the financial decisions made by investors and
companies, including their level of participation in the financial markets and
their willingness to participate in corporate transactions. Severe market
fluctuations or weak economic conditions could reduce our trading volume and
revenues, negatively affect our ability to generate new issue and advisory
revenue, and adversely affect our profitability.



As a general rule, our trading business benefits from increased market
volatility. Increased volatility usually results in increased activity from our
clients and counterparties. However, periods of extreme volatility may at times
result in clients reducing their trading volumes, which would negatively impact
our results. Also, periods of extreme volatility may result in large
fluctuations in securities valuations and we may incur losses on our
holdings. Also, our mortgage group's business benefits when mortgage volumes
increase, and may suffer when mortgage volumes decrease. Among other things,
mortgage volumes are significantly impacted by changes in interest rates.



In addition, as a smaller firm, we are exposed to intense competition. Although
we provide financing to our customers, larger firms have a much greater
capability to provide their clients with financing, giving them a competitive
advantage. We are much more reliant upon our employees' relationships, networks,
and abilities to identify and capitalize on market opportunities. Therefore, our
business may be significantly impacted by the addition or loss of key
personnel.



We try to address these challenges by (i) focusing our business on clients and asset classes that are underserved by the large firms, (ii) continuing to monitor our fixed costs to enhance operating leverage and limit our losses during periods of low volumes, and (iii) attempting to hire and retain entrepreneurial and effective traders and salespeople.

Our business environment is rapidly changing. New risks and uncertainties emerge continuously and it is not possible for us to predict all the risks we will face. This may negatively impact our operating performance.





A portion of our revenue is generated from net trading activity. We engage in
proprietary trading for our own account, provide securities financing for our
customers, and execute "riskless" trades with a customer order in hand resulting
in limited market risk to us. The inventory of securities held for our own
account, as well as held to facilitate customer trades, and our market making
activities are sensitive to market movements.



A portion of our revenue is generated from new issue and advisory engagements.
The fees charged and volume of these engagements are sensitive to the overall
business environment. We provide investment banking and advisory services in
Europe primarily through our subsidiary CCFEL and new issue services in the U.S.
through our subsidiary JVB. Currently, our primary source of new issue revenue
is from originating assets for our U.S. insurance asset management business and
the PriDe funds and managed accounts.



A portion of our revenue is generated from management fees. Our ability to
charge management fees and the amount of those fees is dependent upon the
underlying investment performance and stability of the Investment Vehicles. If
these types of investments do not provide attractive returns to investors, the
demand for such instruments will likely fall, thereby reducing our opportunity
to earn new management fees or maintain existing management fees. As of December
31, 2020, 74.3% of our existing AUM were CDOs. The creation of CDOs has depended
upon a vibrant securitization market. Since 2008, volumes within the
securitization market have dropped significantly and have not fully recovered
since that time. We have not completed a new securitization since 2008. The
remaining portion of our AUM is from a diversified mix of other Investment
Vehicles most of which were more recently formed.



A substantial portion of our asset management revenue is earned from the
management of CDOs. As a result, our asset management revenue has declined from
its historical highs as the assets of the CDOs decline due to maturities,
repayments, auction call redemptions, and defaults. Our ability to complete
securitizations in the future will depend upon, among other things, our asset
origination capacity and success, our ability to arrange warehouse financing to
originate assets, our willingness and capacity to fund required amounts to
obtain warehouse financing and securitized financings, and the demand in the
markets for such securitizations.



A portion of our revenues is generated from our principal investing activities.
Therefore, our revenues are impacted by the overall market supply and demand of
these investments as well as the individual performance of each investment. Our
principal investments are included within other investments, at fair value in
our consolidated balance sheets. See note 9 to our consolidated financial
statements included in this Annual Report on Form 10-K.



The SPAC Market



Beginning in 2018, we began sponsoring a series of SPACs.  Each sponsored SPAC
seeks to complete a business combination with a company involved in the
insurance market.  In addition, we invest in other SPACs at various stages of
their business life cycle.  In 2019 and 2020, these SPAC activities have become
a significant portion of our Principal Investing business segment. In August
2018, we invested in and became the general partner of a series of newly formed
partnerships (the "SPAC Funds"), which were created for the purpose of investing
in the equity interests of SPACs and SPAC sponsor entities including SPACs
sponsored by us, our affiliates, and third parties. As a complement to the SPAC
Funds, we established and became manager of two newly formed umbrella limited
liability companies (the "SPAC Series Funds") that issue a separate series of
interest for each investment portfolio, which typically consists of investments
in the sponsor entities of individual SPACs.  Generally, when a SPAC acquires or
merges with a privately held target company, the target company winds up owning
a majority of the resulting outstanding equity of the SPAC so the transaction is
accounted for as a reverse merger.  Private companies utilize reverse mergers
with SPACs as a method of going public as an alternative to a traditional IPO.
All of our business activity related to SPACs is highly sensitive to the volume
of activity in the SPAC market.  Volumes could be negatively impacted if target
companies no longer see SPACs as an attractive alternative thereby reducing the
number of suitable potential business combination targets.  Also, investor
demand for SPACs would be negatively impacted if the stock of SPACs that
successfully complete a business combination underperform the market.  If
volumes of SPAC activity decline, our results of operations will likely be
significantly negatively impacted.



                                       39
--------------------------------------------------------------------------------

Margin Pressures in Fixed Income Brokerage Business





Performance in the financial services industry in which we operate is highly
correlated to the overall strength of the economy and financial market activity.
Overall market conditions are a product of many factors beyond our control and
can be unpredictable. These factors may affect the financial decisions made by
investors, including their level of participation in the financial markets. In
turn, these decisions may affect our business results. With respect to financial
market activity, our profitability is sensitive to a variety of factors
including the volatility of the equity and fixed income markets, the level and
shape of the various yield curves, and the volume and value of trading in
securities.



Margins and volumes in certain products and markets within the fixed income
brokerage business continue to decrease materially as competition has increased
and general market activity has declined. Further, we continue to expect that
competition will increase over time, resulting in continued margin pressure.



Our response to this margin compression has included: (i) building a diversified
fixed income trading platform; (ii) acquiring or building out new product lines
and expanding existing product lines, including the most recent hiring of
several investment banking professionals within JVB, who are seeking to generate
new issue revenue in the Fintech and SPAC spaces, further expanding our
enterprise-wide SPAC capabilities; (iii) building a hedging execution and
funding operation to service mortgage originators; (iv) becoming a full netting
member of the FICC enabling us to expand our matched book repo business, and
(v) monitoring our fixed costs. Our cost management initiatives are ongoing.
However, there can be no certainty that these efforts will be sufficient. If
insufficient, we will likely see a decline in profitability.



U.S. Housing Market



In recent years, our mortgage group has grown in significance to our Capital
Markets segment and our company overall.  The mortgage group primarily earns
revenue by providing hedging execution, securities financing, and trade
execution services to mortgage originators and other investors in mortgage
backed securities.  Therefore, this group's revenue is highly dependent on the
volume of mortgage originations in the U.S.  Origination activity is highly
sensitive to interest rates, the U.S. job market, housing starts, sale activity
of existing housing stock, as well as the general health of the U.S. economy.
In addition, any new regulation that impacts U.S. government agency mortgage
backed security issuance activity, residential mortgage underwriting standards,
or otherwise impacts mortgage originators will impact our business.  We have no
control over these external factors and there is no effective way for us to
hedge against these risks.  Our mortgage group's volumes and profitability will
be highly impacted by these external factors.



COVID-19 / Impairment of Goodwill





In March 2020, the World Health Organization declared the outbreak of a novel
coronavirus (COVID-19) as a pandemic, which continues to spread throughout the
United States and worldwide. The spread of COVID-19 has caused significant
volatility in domestic and international markets. There is on-going uncertainty
around the breadth and duration of business disruptions related to COVID-19, as
well as its impact on the U.S. and international economies. While we cannot
fully assess the impact COVID-19 will have on all of our operations at this
time, there are certain impacts that we have identified:



   ?  The unprecedented volatility of the financial markets experienced
      since March 2020, has caused us to operate JVB at a lower level of

leverage than prior to the pandemic. Specifically, JVB has reduced the

size of its GCF repo operations and the volume of its TBA trading. We have

determined that at our pre-pandemic levels in these businesses, we were


      exposed to a higher level of counterparty credit risk  and were
      experiencing too much volatility in our available liquidity to
      conservatively meet capital requirements and margin calls in these
      businesses. We expect JVB to operate at lower volumes in both these
      businesses for an indefinite period of time.

? The financial market volatility, as well as the reduction in volumes in

the GCF repo and TBA businesses, that resulted from COVID-19 required us

to reassess the goodwill we had recorded related to JVB under the guidance


      of ASC 350. We determined that the fair value of JVB was less than the
      carrying value (including the goodwill). As a result, we recorded an
      impairment loss of $7,883 in 2020. See note 13 to our consolidated
      financial statements included in this Annual Report on Form 10-K.

? JVB's mortgage group's operations are centered on serving the financial

needs of mortgage originators and institutions that invest in mortgage

backed securities. Prolonged high unemployment could eventually impact

mortgage originations and demand for and supply of mortgage backed

securities, which may have a significant unfavorable impact on the revenue


      earned by JVB's mortgage group.




In 2021, medical professionals developed COVID-19 vaccines and governments began
to distribute them globally, which is expected to reduce virus spread and
further aid economic recovery.  Despite broad improvements, we will likely be
impacted by the pandemic in other ways which we cannot reliably determine. We
will continue to monitor market conditions and respond accordingly.  In April
2020, the Company applied for and received a $2,166 loan under the Paycheck
Protection Program ("PPP") of the Coronavirus Aid, Relief, and Economic Security
("CARES") Act.  See "Recent Events and Transactions" below for additional
information regarding this loan.



                                       40
--------------------------------------------------------------------------------

Recent Events and Transactions





The 2020 Senior Notes



On January 31, 2020, the Operating LLC entered into a note purchase agreement
with JKD Capital Partners I LTD, a New York corporation ("JKD Investor"), and RN
Capital Solutions LLC, a Delaware limited liability company ("RNCS").  The JKD
Investor is owned by Jack DiMaio, the vice chairman of the Company's board of
directors, and his spouse.



Pursuant to the note purchase agreement, JKD Investor and RNCS each purchased a
senior promissory note in the principal amount of $2,250 (for an aggregate
investment of $4,500). The senior promissory notes bear interest at a fixed rate
of 12% per annum and mature on January 31, 2022. On February 3, 2020, pursuant
to the note purchase agreement, the Operating LLC used the proceeds received
from the issuance of the senior promissory notes to the JKD Investor and RNCS to
repay in full all amounts outstanding under the senior promissory note, dated
September 25, 2019, issued by the Company to Pensco Trust Company, Custodian fbo
Edward E. Cohen IRA in the principal amount of $4,386 (the "Cohen IRA
Note"). The Cohen IRA Note was included as a portion of the 2019 Senior Notes
(as defined below) outstanding as of December 31, 2019. The Cohen IRA Note was
fully paid and extinguished on February 3, 2020. Subsequent to this repayment,
$2,400 of the 2019 Senior Notes remain outstanding and are held by EBC.  On
September 25, 2020, the 2019 Senior Notes were amended to extend the maturity
date of the remaining $2,400 to September 25, 2021.  See note 20 to our
financial statements included in this Annual Report on Form 10-K for additional
information regarding the 2019 Senior Notes and the senior promissory notes
issued to the JKD Investor and RNCS.



ViaNova



In 2018, we formed a new subsidiary, ViaNova Capital Group LLC ("ViaNova"), for
the purpose of building a RTL business.  RTLs are small balance commercial loans
secured by first lien mortgages used by professional investors and real estate
developers to finance the purchase and rehabilitation of residential
properties.  ViaNova's business plan included buying, aggregating, and
distributing these loans to produce superior risk-adjusted returns through the
pursuit of opportunities overlooked by commercial banks.



On March 19, 2020, ViaNova received a notice of default from LegacyTexas Bank
regarding the LegacyTexas Credit Facility, stating that ViaNova's unrestricted
cash balance was less than the amount required.  Also, on March 19, 2020,
ViaNova received notice from LegacyTexas Bank that it had suspended funding all
"alternative" loans for all of their clients, including the RTL loans that are
the subject of the LegacyTexas Credit Facility with LegacyTexas Bank.  Since
March 19, 2020, ViaNova repaid all outstanding indebtedness under the
LegacyTexas Credit Facility. ViaNova stopped acquiring new RTLs and does not
intend to acquire any new RTLs in the future.  On August 22, 2020, the Company
sold its investment in ViaNova to the former managing director of ViaNova in
exchange for the managing director's assumption of all of ViaNova's liabilities
and a potential "earn out" of payments from ViaNova to the Company of up to
$500.



CARES Act



On March 27, 2020, the United States enacted the CARES Act. The CARES Act is an
emergency economic stimulus package that includes spending and tax breaks to
strengthen the United States economy and fund a nationwide effort to curtail the
effect of COVID-19. The CARES Act includes significant business tax provisions
that, among other things, include the removal of certain limitations on
utilization of net operating losses, increase the loss carryback period for
certain losses to five years, and increase the ability to deduct interest
expense, as well as amending certain provisions of the previously enacted Tax
Cuts and Jobs Act. We do not expect the CARES Act to have a significant impact
on our tax obligations.


Paycheck Protection Program





In April 2020, we applied for and received a $2,166 loan under the PPP. We have
carefully considered the eligibility requirements for PPP loans as well as
supplemental guidance regarding the PPP beyond the applicable statute issued
from time to time by government agencies and certain government officials. We
were eligible to receive a PPP loan because we have fewer than 100 employees.
Further, although we are a publicly traded company and are listed on the NYSE
American stock exchange, our market capitalization is small relative to many
other publicly traded companies, and we believed that we did not have access to
the public capital markets at the time we applied for and received a loan under
the PPP. In part due to the PPP loan, we do not anticipate any significant
workforce reduction or reductions in compensation levels in the near future. On
September 23, 2020, we applied for forgiveness of the PPP loan.  As of the date
of this report, we have not heard back regarding the forgiveness of the PPP
loan.  See note 20 to our financial statements included in this Annual Report on
Form 10-K for additional information regarding the loan we received under the
PPP.



                                       41

--------------------------------------------------------------------------------





Insurance SPAC



The Operating LLC is the manager of Insurance Acquisition Sponsor, LLC ("IAS")
and Dioptra Advisors , LLC ("Dioptra" and, together with IAS , the "Insurance
SPAC Sponsor Entities").  The Insurance SPAC Sponsor Entities were sponsors of
Insurance Acquisition Corp. ("Insurance SPAC"), a special purpose acquisition
company formed for the purpose of effecting a merger, capital stock exchange,
asset acquisition, stock purchase, reorganization, or similar business
combination with one or more businesses.



On June 29, 2020, Insurance SPAC entered into an Agreement and Plan of Merger
(the "Insurance SPAC Merger Agreement") with IAC Merger Sub, Inc., a Delaware
corporation and direct wholly owned subsidiary of Insurance SPAC ("Insurance
SPAC Merger Sub"), and Shift Technologies, Inc., a Delaware corporation
("Shift").  On October 13, 2020, Insurance SPAC Merger Sub was merged (the
"Insurance SPAC Merger") with and into Shift. In connection with the Insurance
SPAC Merger, the Insurance SPAC changed its name from "Insurance Acquisition
Corp." to "Shift Technologies, Inc." and, on October 15, 2020, the Insurance
SPAC's NASDAQ trading symbol changed from "INSU" to "SFT." The Insurance SPAC
Merger was approved by the Insurance SPAC's stockholders at a special meeting of
stockholders held on October 13, 2020.



Upon the closing of the Insurance SPAC Merger, the Insurance SPAC Sponsor
Entities held 375,000 shares of SFT's Class A Common Stock, par value $0.0001
per share ("SFT Class A Common Stock"), and 187,500 warrants ("SFT Warrants") to
purchase an equal number of shares of SFT Class A Common Stock for $11.50 per
share (such SFT Class A Common Stock and SFT Warrants, collectively, the
"Placement Securities") as a result of the 375,000 placement units which the
Insurance SPAC Sponsor Entities had purchased in a private placement that
occurred simultaneously with the Insurance SPAC's initial public offering on
March 22, 2019.  Further, upon the closing of the Insurance SPAC Merger, the
Insurance SPAC Sponsor Entities collectively held an additional 4,497,525 shares
of SFT Class A Common Stock as a result of its previous purchase of founder
shares of the Insurance SPAC.  In general, when founders shares and placement
shares are discussed as a group, we refer to them as Sponsor Shares. Of the
375,000 placement units, 122,665 were allocable to us.  Of the 4,497,525
founders Shares, 2,019,721 were allocable to us.



As of the closing of the Insurance SPAC Merger, we continued to consolidate the Insurance SPAC Sponsor Entities. Prior to the closing, we treated the consolidated Insurance SPAC Sponsor Entities' investment in the Insurance SPAC as an equity method investment. Effective upon the closing of the Insurance SPAC Merger:

1. We determined the fair value of the Sponsor Shares held by the Insurance SPAC Sponsor Entities.



2.  We reclassified the equity method investment to other investments, at fair
value and recorded principal transactions and other income for the difference
between the fair value of the Sponsor Shares held by the Insurance SPAC Sponsor
Entities and the equity method investment balance immediately prior to the
merger closing.

3.  We then recorded non-controlling interest expense or compensation expense
related to the Sponsor Shares distributable to the non-controlling interest
holders in the Insurance SPAC Sponsor Entities.  If the non-controlling interest
holder was an employee, we recorded the expense as equity-based compensation
expense.  Otherwise, the expense was recorded as non-controlling interest
expense.



Subsequent to the closing of the Insurance SPAC Merger, any change in the fair
value of the shares held by the Insurance SPAC Sponsor Entities has
been recorded as a component of principal transactions and other income.  We
concurrently record a corresponding non-controlling interest entry related to
the Sponsor Shares distributable to the non-controlling interest holders in the
Insurance SPAC Sponsor Entities.  No adjustment is made to the equity-based
compensation expense recorded as of the closing of the Insurance SPAC Merger.
Rather, all post-merger changes in value related to Sponsor Shares distributable
to the non-controlling interest holders in the Insurance SPAC Sponsor Entities
are recorded as non-controlling interest expense.



In December 2020, the Insurance SPAC Sponsor Entities distributed a portion of
the Sponsor Shares held to the Operating LLC or other wholly owned subsidiaries
of the Operating LLC; and the non-controlling interest holders, in a partial
liquidating distribution of the Insurance SPAC Sponsor Entities.  For the
Sponsor Shares we hold outside of the Insurance SPAC Sponsor Entities, we record
principal transactions and other income for any change in their value.  In this
case, there is no corresponding non-controlling interest income or expense. 

We


expect the Insurance SPAC Sponsor Entities to distribute all of their holdings
of Sponsor Shares and fully liquidate the Insurance SPAC Sponsor Entities in the
first quarter of 2021.



Concurrently with the closing of the Insurance SPAC Merger, a subsidiary of the
Operating LLC, INSU Pipe Sponsor, LLC, purchased 600,000 shares of SFT Class A
Common Stock at a purchase price per share of $10.00 pursuant to a subscription
agreement that such subsidiary executed at the time of the execution of the
Insurance SPAC Merger Agreement. Our interest in INSU Pipe Sponsor LLC entitled
us to an allocation of 350,000 shares of SFT Class A Common Stock.  During 2020,
we consolidated INSU Pipe Sponsor, LLC and recorded principal transactions and
other income for the full 600,000 shares and then non-controlling interest
expense or income for the 250,000 shares not owned by us.  In December 2020, the
shares of SFT Class A Common Stock were registered for sale and INSU Pipe
Sponsor, LLC distributed the shares to the non-controlling interest holders
resulting in INSU Pipe Sponsor, LLC being 100% owned by the Operating LLC.  INSU
Pipe Sponsor, LLC was dissolved in the first quarter of 2021, and our 350,000
shares transferred to the Operating LLC or other wholly owned subsidiary of the
Operating LLC.  The following table details the impact of all the entries
associated with the Insurance SPAC during 2020.  This table excludes any tax
impact.



                                                             Year Ended December 31, 2020
                                            Insurance
                                           SPAC Sponsor       INSU Pipe
                                             Entities       Sponsor, LLC       Operating LLC        Total
Principal transactions and other income    $     41,035     $        (842 )   $           426     $  40,619
Equity-based compensation                       (11,700 )               -                   -       (11,700 )
Other operating                                      (2 )               -                   -            (2 )
Income / (loss) from equity method
affiliates                                       (3,138 )               -                   -        (3,138 )
Net income / (loss)                              26,195              (842 )               426        25,779
Less: Net (loss) income attributable to
the non-controlling interest - Operating
LLC                                              (9,328 )             410                   -        (8,918 )
Net income / (loss) - Operating LLC              16,867              (432 )               426        16,861
Less: Net income / (loss) attributable
to the convertible non-controlling
interest                                         12,205              (313 )               308        12,200
Net income / (loss) attributable to
Cohen & Company Inc.                       $      4,662     $        (119 )   $           118     $   4,661




As of December 31, 2020, the Operating LLC's total investment in Shift of
$36,395 is included as a component of other investments, at fair value in our
consolidated balance sheet.  Offsetting this is $1,337 included as other
investments sold, not yet purchased and $16,686 of non-controlling interest in
our consolidated balance sheet related to shares of Shift held in consolidated
entities that are distributable to the non-controlling interest holders.
Therefore, the Operating LLC's share of the consolidated investment in Shift as
of December 31, 2020 was $18,372.  See note 4 to our financial statements
included in this Annual Report on Form 10-K.

                                       42
--------------------------------------------------------------------------------

INSU Acquisition Corp. II ("Insurance SPAC II")

The Operating LLC is the manager of Insurance Acquisition Sponsor II, LLC ("IAS
II") and Dioptra Advisors II, LLC ("Dioptra II" and, together with IAS II, the
"Insurance SPAC II Sponsor Entities"). The Insurance SPAC II Sponsor Entities
are sponsors of INSU Acquisition Corp. II ("Insurance SPAC II"), a blank check
company that sought to effect a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business combination with
one or more businesses (each a "Insurance SPAC II Business Combination").



On November 24, 2020, Insurance SPAC II entered into an Agreement and Plan of
Merger and Reorganization (the "Insurance SPAC II Merger Agreement") with INSU
II Merger Sub Corp., a Delaware corporation and direct wholly owned subsidiary
of Insurance SPAC II ("Insurance SPAC II Merger Sub"), and MetroMile, Inc., a
Delaware corporation (at the time, named MetroMile Operating Company)
("MetroMile"). The Insurance SPAC II Merger Agreement provided for, among other
things, the acquisition of MetroMile by Insurance SPAC II pursuant to the
proposed merger of Insurance SPAC II Merger Sub with and into MetroMile with
MetroMile continuing as the surviving entity and a direct wholly owned
subsidiary of Insurance SPAC II (the "Insurance SPAC II Merger").  On February
9, 2021, the Insurance SPAC II Merger was consummated and Insurance SPAC II
changed its name to MetroMile.



Upon closing of the Insurance SPAC II Merger, the Insurance SPAC II Sponsor Entities received a total of 6,669,667 founder shares and 452,500 placement units.





Each placement unit consists of one share of Insurance SPAC II Common Stock and
one-third of one warrant (the "Insurance SPAC II Warrant").  Each whole
Insurance SPAC II Warrant entitles the holder to purchase one share of Insurance
SPAC II common stock for $11.50 per share.  Of the 6,669,667 founders shares,
(i) 1,569,333 founder shares were freely transferable and saleable at the
closing as of the Insurance SPAC II Merger, (ii) 2,550,167 founder shares will
become freely transferable and saleable at such time as MetroMile's stock price
is greater than $15.00 per share for any period of 20 trading days out of 30
consecutive trading days; (iii) 2,550,167 founder shares will become freely
transferable and saleable at such time as MetroMile's stock price is greater
than $17.00 per share for any period of 20 trading days out of 30 consecutive
trading days.



We currently consolidate the Insurance SPAC II Sponsor Entities and prior to the
Insurance SPAC II Merger treated their investment in the Insurance SPAC II as an
equity method investment.  Effective upon the closing of the Insurance SPAC
II Merger on February 9, 2021, we reclassified the equity method investment in
the Insurance SPAC II to other investments, at fair value and adopted fair value
accounting for the investment in MetroMile, resulting in an amount of principal
transaction revenue derived from the (i) the Sponsor Shares retained by the
Insurance SPAC II Sponsor Entities described in the previous paragraph; (ii) the
trading share price of MetroMile's common stock and the MetroMile Warrants; and
(iii) fair value discounts related to the share sale restrictions on the Sponsor
Shares.  Upon recognition of the principal transaction revenue described above,
we recorded non-controlling interest expense or compensation expense related to
the amount of Sponsor Shares distributable to the non-controlling interest
holders in the Insurance SPAC II Sponsor Entities.  If the non-controlling
interest holder is an employee of the Company, the expense is recorded as
compensation.  Otherwise, the expense is non-controlling interest expense.



Of the Sponsor Shares retained by the Insurance SPAC II Sponsor Entities, the
amount to be allocable to the Operating LLC included (i) 765,833 founder shares
that are freely transferable and saleable at the closing of the Insurance SPAC
II Merger, (ii) 1,244,479 founder shares that will become freely transferable
and saleable at such time as MetroMile's stock price is greater than $15.00 per
share for any period of 20 trading days out of 30 consecutive trading days; and
(iii) 1,244,479 founder shares that will become freely transferable and
saleable in full at such time as MetroMile's stock price is greater than $17.00
per share for any period of 20 trading days out of 30 consecutive trading days.



 As of December 31, 2020, we had a total equity method investment in Insurance
SPAC II of $4,064 which was included as a component of investment in equity
method affiliates in our consolidated balance sheet.  Offsetting this amount was
non-controlling interest of $4,295 which was included as a component of
non-controlling interest in our consolidated balance sheet.  Therefore, the net
carrying value of our investment in Insurance SPAC II was $(231) as of December
31, 2020.  See note 4 to our financial statements included in this Annual Report
on Form 10-K.



                                       43

--------------------------------------------------------------------------------

INSU Acquisition Corp III ("Insurance SPAC III")

The Operating LLC is the manager of Insurance Acquisition Sponsor III, LLC ("IAS
III") and Dioptra Advisors III, LLC (together with IAS III, the "Insurance SPAC
III Sponsor Entities"). On December 22, 2020, INSU Acquisition Corp. III
completed the sale of 25,000,000 units (the "Insurance SPAC III Units") in its
initial public offering which includes 3,200,000 units issued pursuant to the
underwriters' over-allotment option.



Each Insurance SPAC III Unit consists of one share of Class A common stock, par
value $0.0001 per share ("Insurance SPAC III Common Stock"), and one-third of
one warrant (each, an "Insurance SPAC III Warrant"), where each whole Insurance
SPAC III Warrant entitles the holder to purchase one share of Insurance SPAC III
Common Stock for $11.50 per share. The Insurance SPAC III Units were sold in the
IPO at an offering price of $10.00 per Unit, for gross proceeds of
$250,000 (before underwriting discounts and commissions and offering expenses).
Pursuant to the underwriting agreement in the IPO, Insurance SPAC III granted
the underwriters in the IPO (the "Insurance SPAC III Underwriters") a 45-day
option to purchase up to 3,270,000 additional Insurance SPAC III units solely to
cover over-allotments, if any; and on December 21, 2020, the Insurance SPAC III
Underwriters notified the Company that they were partially exercising the
over-allotment option for 3,200,000 Units and waiving the remainder of the
over-allotment option. Immediately following the completion of the IPO, there
were an aggregate of 34,100,000 shares of Insurance SPAC III Common Stock issued
and outstanding.  If the Insurance SPAC III fails to consummate a business
combination within the first 24 months following the IPO, its corporate
existence will cease except for the purposes of winding up its affairs and
liquidating its assets.



The Insurance SPAC III Sponsor Entities purchased an aggregate of 575,000 of
placement units in a private placement that occurred simultaneously with the IPO
for an aggregate of $5,750, or $10.00 per placement unit. Each placement unit
consists of one share of Insurance SPAC III Common Stock and one-third of one
warrant (the "Insurance SPAC III Placement Warrant"). The Insurance SPAC III
placement units are identical to the Insurance SPAC III Units sold in the IPO
except (i) the shares of Insurance SPAC III Common Stock issued as part of the
placement units and the Insurance SPAC III Warrants will not be redeemable by
Insurance SPAC III, (ii) the Insurance SPAC III Warrants may be exercised by the
holders on a cashless basis, and (iii) the shares of Insurance SPAC III Common
Stock issued as part of the placement units, together with the Insurance SPAC
III Warrants, are entitled to certain registration rights. Subject to certain
limited exceptions, the placement units (including the underlying Insurance SPAC
III Warrants and Insurance SPAC III Common Stock and the shares of Insurance
SPAC III Common Stock issuable upon exercise of the Insurance SPAC III Warrants)
will not be transferable, assignable or salable until 30 days after the
completion of the Insurance SPAC III's initial business combination.



A total of $250,000 of the net proceeds from the private placement and the IPO
(including approximately $10,600 of the deferred underwriting commission from
the IPO) were placed in a trust account. Except for the withdrawal of interest
to pay taxes (or dissolution expenses if a business combination is not
consummated), none of the funds held in the trust account will be released until
the earlier of (i) the completion of Insurance SPAC III's initial business
combination, (ii) in connection with a stockholder vote to amend the Insurance
SPAC III's amended and restated certificate of incorporation (A) to modify the
substance or timing of Insurance SPAC III's obligation to redeem 100% of its
public shares if it does not complete an initial business combination within 24
months from the completion of the IPO or (B) with respect to any other provision
relating to stockholders' rights or preinitial business combination activity, or
(iii) the redemption of all of Insurance SPAC III's public shares issued in the
IPO if the Insurance SPAC III is unable to consummate an initial business
combination within 24 months from the completion of the IPO. If Insurance SPAC
III does not complete a business combination within the first 24 months
following the IPO, the placement units will expire worthless.



The Insurance SPAC III Sponsor Entities collectively hold 8,525,000 founder
shares. Subject to certain limited exceptions, the founder shares will not be
transferable or salable except (a) with respect to 25% of such shares, until
consummation of a business combination, and (b) with respect to additional 25%
tranches of such shares, when the closing price of Insurance SPAC III Common
Stock exceeds $12.00, $13.50, and $17.00, respectively, for 20 out of any 30
consecutive trading days following the consummation of a business combination.
Certain non-controlling interests in the Insurance SPAC III Sponsor Entities,
including executive and key employees of the Operating LLC, purchased membership
interests in the Insurance SPAC III Sponsor Entities and, in addition to having
an interest in Insurance SPAC III's placement units discussed above, have an
interest in Insurance SPAC III's founder shares through such membership
interests in the Insurance SPAC III Sponsor Entities. The number of the
Insurance SPAC III's founders shares in which such non-controlling interests in
the Insurance SPAC III Sponsor Entities, including such executives and key
employees of the Operating LLC, have an interest in through the Insurance SPAC
III Sponsor Entities will not be finally and definitively determined until
consummation of a business combination. The number of the Insurance SPAC III's
founder shares currently allocated to the Operating LLC is 4,467,500, but such
number of founder shares will also not be finally and definitively determined
until the consummation of a business combination.



As of December 31, 2020, we had a total equity method investment in Insurance
SPAC III of $5,741, which was included as a component of investment in equity
method affiliates in our consolidated balance sheet.  Partially offsetting this
amount was non-controlling interest of $5,416, which was included as a component
of non-controlling interest in our consolidated balance sheet.  Therefore, the
net carrying value of our investment in Insurance SPAC III was $325 as of
December 31, 2020. See note 4 to our financial statements included in this
Annual Report on Form 10-K.



                                       44
--------------------------------------------------------------------------------

DGC Trust/CBF Redeemable Financial Instrument





On September 29, 2017, the Operating LLC entered into investment agreements with
CBF (the "CBF Investment Agreement") and the DGC Family Fintech Trust (the "DGC
Trust"), a trust established by Daniel G. Cohen (the "DGC Trust Investment
Agreement"), pursuant to which CBF and the DGC Trust agreed to invest $8,000 and
$2,000, respectively, into the Operating LLC.



As of September 25, 2020, the Company had outstanding investment balances of $6,500 and $2,000 related to the CBF Investment Agreement and the DGC Trust Investment Agreement, respectively.





On September 25, 2020, the Operating LLC and CBF entered into Amendment No. 3 to
the CBF Investment Agreement, which amended the CBF Investment Agreement (i) to
extend the date thereunder pursuant to which the Company or CBF could cause a
redemption of the Investment Balance from September 27, 2020 to January 1, 2021,
and (ii) to state that no such redemption by the Company could be in violation
of any loan agreement to which the Company was then a party.



On September 30, 2020, the Company redeemed the DGC Trust Investment Agreement in full by making payment of $2,000 to the DGC Trust.





On October 9, 2020 and effective October 15, 2020, the Operating LLC entered
into Amendment No. 4 to the CBF Investment Agreement, which further amended the
CBF Investment Agreement to, among other things, (A) decrease the "Investment
Amount" under the CBF Investment Agreement from $6,500 to $4,000 in exchange for
a one-time payment of $2,500 from the Operating LLC to CBF; and (B) provide that
the term "Investment Return" (as defined in the CBF Investment Agreement) will
mean an annual return equal to, (i) for any twelve-month period following
September 29, 2020 (each, an "Annual Period") in which the revenue of the
business of JVB ("Revenue of the Business"), is greater than zero, the greater
of 20% of the Investment Amount or 9.4% of the Revenue of the Business, or
(ii) for any Annual Period in which the Revenue of the Business is zero or less
than zero, 3.75% of the Investment Amount. Prior to the amendment No. 4 to the
CBF Investment Agreement, the term "Investment Return" under the CBF Investment
Agreement was defined as (A) with respect to any Annual Period in which the
Revenue of the Business was greater than zero, the greater of 20% of the
Investment Amount or 15.2% of the Revenue of the Business, or (ii) for any
Annual Period in which the Revenue of the Business was zero or less than zero,
3.75% of the Investment Amount.  The Company made the $2,500 payment to CBF on
October 15, 2020.  Furthermore, subsequent to December 31, 2020, we have given
notice to CBF that we intend to redeem the remaining $4,000 investment on or
around March 31, 2021.



                                       45

--------------------------------------------------------------------------------

Table of Contents

Consolidated Results of Operations

The following section provides a comparative discussion of our consolidated results of operations for the specified periods. The period-to-period comparisons of financial results are not necessarily indicative of future results.

Year Ended December 31, 2020 Compared to the Year Ended December 31, 2019

The following table sets forth information regarding our consolidated results of operations for the years ended December 31, 2020 and 2019.

COHEN & COMPANY INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
       (Dollars in Thousands)
             (Unaudited)




                                              Year Ended December 31,           Favorable / (Unfavorable)
                                               2020              2019           $ Change           % Change
Revenues
Net trading                                $      73,611       $  38,172     $       35,439                93 %
Asset management                                   8,759           7,560              1,199                16 %
New issue and advisory                             2,234           1,831                403                22 %
Principal transactions and other income           45,506           2,103             43,403              2064 %
Total revenues                                   130,110          49,666             80,444               162 %

Operating expenses
Compensation and benefits                         59,902          25,972            (33,930 )            (131 )%
Business development, occupancy,
equipment                                          2,708           3,402                694                20 %
Subscriptions, clearing, and execution             9,887           9,682               (205 )              (2 )%
Professional fee and other operating               7,068           6,251               (817 )             (13 )%
Depreciation and amortization                        334             318                (16 )              (5 )%
Impairment of goodwill                             7,883               -             (7,883 )              NM
Total operating expenses                          87,782          45,625            (42,157 )             (92 )%

Operating income / (loss)                         42,328           4,041             38,287               947 %

Non-operating income / (expense)



Interest expense, net                             (9,589 )        (7,584 )           (2,005 )             (26 )%
Income / (loss) from equity method
affiliates                                        (2,955 )          (553 )           (2,402 )            (434 )%
Income / (loss) before income taxes               29,784          (4,096 )           33,880               827 %
Income tax expense / (benefit)                    (8,669 )          (523 )            8,146              1558 %
Net income / (loss)                               38,453          (3,573 )           42,026              1176 %
Less: Net income (loss) attributable to
the non-controlling interest                      24,248          (1,519 )          (25,767 )           (1696 )%
Net income / (loss) attributable to
Cohen & Company Inc.                       $      14,205       $  (2,054 )   $       16,259               792 %




Revenues



Revenues increased by $80,444, or 162%, to $130,110 for the year ended December
31, 2020, as compared to $49,666 for the year ended December 31, 2019. As
discussed in more detail below, the change was comprised of (i) an increase of
$35,439 in net trading revenue; (ii) an increase of $1,199 in asset management
revenue; (iii) an increase of $403 in new issue and advisory revenue; and (iv)
an increase of $43,403 in principal transactions and other income.



                                       46

--------------------------------------------------------------------------------


  Table of Contents



Net Trading


Net trading revenue increased by $35,439, or 93%, to $73,611 for the year ended December 31, 2020, as compared to $38,172 for the year ended December 31, 2019. The following table shows the detail by trading group.







     NET TRADING
(Dollars in Thousands)




                                  Year Ended December 31,
                               2020         2019        Change
Mortgage                     $  9,641     $  6,780     $  2,861
Matched book repo              33,980       12,011       21,969
High yield corporate            8,342        5,989        2,353
Investment grade corporate      9,978          565        9,413
Wholesale and other            11,670       12,827       (1,157 )
Total                        $ 73,611     $ 38,172     $ 35,439




Our net trading revenue includes unrealized gains on our trading investments, as
of the applicable measurement date that may never be realized due to changes in
market or other conditions not in our control. This may adversely affect the
ultimate value realized from these investments. In addition, our net trading
revenue also includes realized gains on certain proprietary trading positions.
Our ability to derive trading gains from such trading positions is subject to
overall market conditions. Due to volatility and uncertainty in the capital
markets, the net trading revenue recognized during the year may not be
indicative of future results. Furthermore, from time to time, some of the assets
included in the Investments-trading line of our consolidated balance sheets
represent level 3 valuations within the FASB valuation hierarchy. Level 3 assets
are carried at fair value based on estimates derived using internal valuation
models and other estimates. See notes 9 and 10 to our consolidated financial
statements included in this Annual Report on Form 10-K. The fair value estimates
made by us may not be indicative of the final sale price at which these assets
may be sold.


We consider our matched book repo business to be subject to significant concentration risk. See note 11 to our consolidated financial statements included in this Annual Report on Form 10-K.





Asset Management



Assets Under Management


Our AUM equals the sum of: (1) the gross assets included in CDOs that we have sponsored and manage; plus (2) the NAV of investment funds we manage; plus (3) the NAV or gross assets of other accounts we manage.

Our calculation of AUM may differ from the calculations used by other asset managers and, as a result, this measure may not be comparable to similar measures presented by other asset managers. This definition of AUM is not necessarily identical to the definitions of AUM that may be used in our management agreements.







ASSETS UNDER MANAGEMENT
(Dollars in Thousands)




                                            As of December 31,
                                   2020            2019            2018

Company sponsored CDOs $ 2,057,178 $ 2,197,208 $ 2,386,614 Other Investment Vehicles (1) 712,028 559,382 465,665 Assets under management (2) $ 2,769,206 $ 2,756,590 $ 2,852,279

(1) Other Investment Vehicles include any Investment Vehicle that is not a

Company sponsored CDO. (2) In some cases, accounts we manage employ leverage. In some cases, our fees

are based on gross assets while in other cases our fees are based on net

assets. AUM included herein is calculated using either the gross or net

assets of each Investment Vehicle based on whichever serves as the basis for


    calculation of our management fees.




                                       47

--------------------------------------------------------------------------------

Table of Contents





Asset management fees increased by $1,199, or 16%, to $8,759 for the year ended
December 31, 2020, as compared to $7,560 for the year ended December 31, 2019,
as discussed in more detail below.



   ASSET MANAGEMENT
(Dollars in Thousands)




            Year Ended December 31,
          2020        2019       Change
CDOs    $  3,407     $ 4,028     $  (621 )
Other      5,352       3,532       1,820
Total   $  8,759     $ 7,560     $ 1,199




CDOs



A substantial portion of our asset management fees are earned from the
management of CDOs. We have not completed a new securitization since 2008. As a
result, our asset management revenue from CDOs has declined from its historical
highs as the assets of the CDOs decline due to maturities, repayments, auction
call redemptions, and defaults. Our ability to complete securitizations in the
future will depend upon, among other things, our asset origination capacity and
success, our ability to arrange warehouse financing to originate assets, our
willingness and capacity to fund required amounts to obtain warehouse financing
and securitized financings, and the demand in the markets for such
securitizations.



Asset management revenue from Company-sponsored CDOs decreased by $621 to
$3,407 for the year ended December 31, 2020, as compared to $4,028 for the year
ended December 31, 2019. The following table summarizes the periods presented by
asset class.





FEES EARNED BY ASSET CLASS
  (Dollars in Thousands)




                                                 Year Ended December 31,
                                              2020         2019       Change
TruPS and insurance company debt - U.S.     $   2,922     $ 3,113     $  (191 )
TruPS and insurance company debt - Europe         381         369          12
Broadly syndicated loans - Europe                 104         546        (442 )
Total                                       $   3,407     $ 4,028     $  (621 )




The reduction in asset management fees for TruPS and insurance company debt -
U.S. was a result of average AUM declining due to principal repayments on the
assets in these securitizations.  Asset management fees for TruPS and insurance
company debt - Europe remained flat.  Asset management fees for broadly
syndicated loans - Europe consisted of a single CLO. During August 2019, this
CLO liquidated.  The revenues earned during 2020 represented final fees earned
by us upon successful liquidation. No future revenue will be earned related to
this management contract.



Other



Other asset management revenue increased by $1,820 to $5,352 for the year ended
December 31, 2020, as compared to $3,532 for the year ended December 31, 2019.
The increase was due to an increase in AUM and an increase in incentive
management fees earned.



New Issue and Advisory Revenue





New issue and advisory revenue increased by $403, or 22%, to $2,234 for the year
ended December 31, 2020, as compared to $1,831 for the year ended December 31,
2019.



                                       48

--------------------------------------------------------------------------------

Table of Contents





Our revenue earned from new issue and advisory has been, and we expect will
continue to be, volatile. We earn revenue from a limited number of engagements.
Therefore, a small change in the number of engagements can result in large
fluctuations in the revenue recognized. Further, even if the number of
engagements remains consistent, the average revenue per engagement can fluctuate
considerably. Finally, our revenue is generally earned when an underlying
transaction closes (rather than on a monthly or quarterly basis). Therefore, the
timing of underlying transactions increases the volatility of our revenue
recognition.



In addition, we often incur certain costs related to new issue
engagements. These costs are included as a component of either subscriptions,
clearing and execution, or professional fees and other and will generally be
recognized in the same period that the related revenue is recognized.



Principal Transactions and Other Income





Principal transactions and other income increased by $43,403 to $45,506 for the
year ended December 31, 2020, as compared to $2,103 for the year ended December
31, 2019.


PRINCIPAL TRANSACTIONS & OTHER INCOME


       (Dollars in Thousands)




                                                     Year Ended December 31,
                                                  2020        2019        Change
SFT                                             $ 40,619     $     -     $ 40,619
EuroDekania                                            -         279         (279 )
Currency hedges                                        -          51          (51 )
CLO investments                                     (535 )       258         (793 )
Other SPAC equity                                  1,503         116        1,387
IMXI                                               2,703         172        2,531
U.S. Insurance JV                                    222         150           72
SPAC Funds                                           183          29          154
Other principal investments                            7         465         (458 )
Total principal transactions                      44,702       1,520       43,182

IIFC revenue share                                   491         531          (40 )
All other income / (loss)                            313          52          261
Other income                                         804         583          221

Total principal transactions and other income $ 45,506 $ 2,103 $ 43,403






Principal Transactions



Shift is a publicly traded company.  The shares of Shift we hold are comprised
of both unrestricted and restricted shares and are carried at fair value.  See
note 4 for discussion of sale restrictions on these shares.  See note 9 to our
consolidated financial statements included in this Annual Report on Form 10-K
for information about how we determine the value of these instruments.  The
income recognized is mostly comprised of income of the Insurance SPAC Sponsor
Entities and another consolidated subsidiary; both of which are not wholly
owned.  See compensation and non-controlling interest discussion below.



EuroDekania was a company that invested in hybrid capital securities of European
companies and we carried our investment at the reported NAV. Income recognized
in 2019 was the result of changes in the underlying NAV of the fund as well as
distributions received. EuroDekania sold its remaining investments and
liquidated in 2019.



Our currency hedge consisted of a Euro forward agreement designed to hedge the
currency risk primarily associated with our investment in EuroDekania. We
terminated this hedge during 2019 and do not expect to enter into this hedge
going forward.



The CLO investments represent investments in the most junior tranche of certain
CLOs. These investments were carried at fair value. See note 9 to our
consolidated financial statements included in this Annual Report on Form 10-K
for information about how we determine the value of these instruments.  These
investments were fully liquidated in 2020.



Other SPAC equity represents equity investments in publicly traded SPACs.  See
note 9 to our consolidated financial statements included in this Annual Report
on Form 10-K for information about how we determined the value of these
instruments.



IMXI represents unrestricted and restricted equity positions of International
Money Express, Inc. (NASDAQ: IMXI), a publicly traded company that resulted from
the merger of Intermex Holdings, LLC and FinTech Acquisition Corp. II. See note
9 to our consolidated financial statements included in this Annual Report on
Form 10-K for information about how we determine the value of these
instruments. Also see note 4 and 31 to our consolidated financial statements
included in this Annual Report on Form 10-K.



                                       49

--------------------------------------------------------------------------------

Table of Contents





The U.S. Insurance JV is a company that invests in USD denominated debt issued
by small insurance and reinsurance companies and we carry our investment at its
NAV.  Income recognized in each period is the result of changes in the
underlying NAV of the fund as well as distributions received. See notes 4 and 10
to our consolidated financial statements included in this Annual Report on Form
10-K.



The SPAC Funds primarily invest in the equity of SPACs and we carry our
investment at its reported NAV.  Income recognized in each period is the result
of changes in the underlying NAV of the SPAC Funds as well as distributions
received. See notes 4 and 9 to our consolidated financial statements included in
this Annual Report on Form 10-K.



Other Income


Other income increased by $221 to $804 for the year ended December 31, 2020, as compared to $583 for the year ended December 31, 2019.

The revenue share arrangement noted in the table above entitles us to a percentage of revenue earned by IIFC. The IIFC revenue share arrangement expires at the earlier of (i) the dissolution of IIFC or (ii) when we have earned a cumulative $20,000 in revenue share payments. To date, we have earned $3,178. In addition, in any particular year, the revenue share earned by us cannot exceed $2,000.





Operating Expenses



Operating expenses increased by $42,157, or 92%, to $87,782 for the year ended
December 31, 2020, as compared to $45,625 for the year ended December 31, 2019.
As discussed in more detail below, the change was comprised of (i) an
increase of $33,930 in compensation and benefits; (ii) a decrease of $694 in
business development, occupancy, and equipment; (iii) an increase of $205 in
subscriptions, clearing, and execution; (iv) an increase of $817 in professional
fee and other operating; (v) an increase of $16 in depreciation and
amortization; and (vi) an impairment of goodwill of $7,883.



Compensation and Benefits



Compensation and benefits increased by $33,930, or 131%, to $59,902 for the year
ended December 31, 2020, as compared to $25,972 for the year ended December 31,
2019.





COMPENSATION AND BENEFITS
 (Dollars in Thousands)




                                      Year Ended December 31,
                                   2020         2019        Change

Cash compensation and benefits $ 47,349 $ 25,228 $ 22,121 Equity-based compensation 12,553 744 11,809 Total

$ 59,902     $ 25,972     $ 33,930




Cash compensation and benefits in the table above is primarily comprised of
salary, incentive compensation, and benefits. Cash compensation and benefits
increased by $22,121 to $47,349 for the year ended December 31, 2020, as
compared to $25,228 for the year ended December 31, 2019. Our headcount
decreased to 87 as of December 31, 2020 from 94 as of December 31, 2019.  Cash
compensation increased primarily due to an increase in incentive compensation
related to the increase in net trading revenue and overall firm income.



Equity-based compensation increased by $11,809 to $12,553 for the year ended
December 31, 2020, as compared to $744 for the year ended December 31, 2019.  Of
the $12,553 of equity compensation recognized in 2020, $11,700 was due to
equity-based compensation related to the issuance of membership units of the
Insurance SPAC Sponsor Entities to employees of the Company.  This expense was
recognized upon the completion of the merger between the Insurance SPAC and
Shift in October 2020.  No further equity-based compensation expense will be
recognized related to membership units of the Insurance SPAC Sponsor Entities in
the future.  Following the business combination forward, the membership units
of the Insurance SPAC Sponsor Entities held by employees will be treated as part
of the non-controlling interest.



The Insurance SPAC II Sponsor Entities and Insurance SPAC III Sponsor Entities
have also issued membership units to employees of the Company.  If the Insurance
SPAC II or Insurance SPAC III successfully complete a business combination, the
Company will also recognize significant equity compensation expense related to
these issuances.  The amount of future equity-based compensation expense that
will be recognized if these business combinations are completed will be
dependent upon the total number of founders shares ultimately allocable to
employees and the value of the shares upon the completion of the business
combination.  See notes 4 and 22 to our consolidated financial statements
included in this Annual Report on Form 10-K.



The remaining $853 of equity-based compensation recognized during 2020
relates to restricted grants of the Company's Common Stock and Operating LLC
units.  This amount increased by $109 as compared to $744 for the prior year.
This increase was due to a higher grant date fair value of issuances during 2020
as compared to 2019.


Business Development, Occupancy, and Equipment





Business development, occupancy, and equipment decreased by $694, or 20%, to
$2,708 for the year ended December 31, 2020, as compared to $3,402 for the year
ended December 31, 2019. Of the decrease, $630 was due to reduced business
development costs due to reduced travel and entertainment as a result of the
COVID-19 pandemic.  The remainder of the decrease was due to reduced occupancy
and equipment costs of $64.



                                       50

--------------------------------------------------------------------------------

Table of Contents

Subscriptions, Clearing, and Execution

Subscriptions, clearing, and execution increased by $205, or 2%, to $9,887 for the year ended December 31, 2020, as compared to $9,682 for the year ended December 31, 2019. Subscriptions expenses declined by $7 and clearing and execution increased by $212.

Professional Fee and Other Operating Expenses





Professional fee and other operating expenses increased by $817, or 13%, to
$7,068 for the year ended December 31, 2020, as compared to $6,251 for the year
ended December 31, 2019. Professional fees increased $680 and other operating
expenses increased by $137.


Depreciation and Amortization

Depreciation and amortization increased by $16, or 5%, to $334 for the year ended December 31, 2020, as compared to $318 for the year ended December 31, 2019.





Impairment of Goodwill



We determined the financial market volatility, as well as the reduction in
volumes in the GCF repo and TBA businesses that resulted from COVID-19 was a
triggering event that required us to reassess the goodwill we had recorded
related to JVB under the guidance of ASC 350. We determined that the fair value
of JVB was less than its carrying value (including the goodwill). As a result,
we recorded an impairment of $7,883 in 2020. See note 13 to our consolidated
financial statements included in this Annual Report on Form 10-K.



Non-Operating Income and Expense





Interest Expense, net


Interest expense, net increased by $2,005 to $9,589 for the year ended December 31, 2020, as compared to $7,584 for the year ended December 31, 2019.









   INTEREST EXPENSE
(Dollars in Thousands)




                                                         Year Ended December 31,
                                                   2020            2019           Change
Junior subordinated notes                      $      2,882     $     3,457     $      (575 )
2020 Senior Notes                                       496               -             496
2013 Convertible Notes / 2019 Senior Notes              336             615            (279 )
2017 Convertible Note                                 1,505           1,472              33
Line of Credit (Byline / FT)                          1,102             365             737
Redeemable Financial Instrument - DGC Trust
/ CBF                                                 1,490           1,166             324
Redeemable Financial Instrument - JKD
Capital Partners I LTD                                1,883             699 

1,184


Redeemable Financial Instrument - ViaNova
Capital Group, LLC                                     (105 )          (190 )            85
                                               $      9,589     $     7,584     $     2,005

See notes 19 and 20 to our consolidated financial statements included in this Annual Report on Form 10-K.

Income / (loss) from Equity Method Affiliates





Income / (loss) from equity method affiliates decreased by
$2,402 to ($2,955) for the year ended December 31, 2020 from ($553) for the year
ended December 31, 2019.  See note 12 to our consolidated financial statements
included in this Annual Report on Form 10-K.





                            Year Ended December 31,
                          2020        2019       Change
Insurance SPACs         $ (3,656 )   $ (553 )   $ (3,103 )
SPAC Sponsor Entities        (18 )        -          (18 )
AOI                          360          -          360
CK Capital                   278          -          278
SPAC Series Funds             81          -           81
                        $ (2,955 )   $ (553 )   $ (2,402 )






                                       51

--------------------------------------------------------------------------------

Income Tax Expense / (Benefit)

The income tax expense / (benefit) was ($8,669) for the year ended December 31, 2020, as compared to ($523) for the year ended December 31, 2019.





The tax benefit recognized in 2020 was comprised of a deferred tax benefit of
$8,877, partially offset by current tax expense of $208. The current tax expense
incurred in 2020 was the result of foreign, state, and local income tax. The
deferred tax benefit was a U.S. tax benefit, which was the result of the
reduction in the valuation allowance applied against the Company's net operating
loss carryforward ("NOL") and net capital loss carryforward ("NCL") tax assets.
Prior to 2020, we had concluded that due to our recent history of tax losses, we
should only recognize our NOL asset to the extent the reversal of our deferred
tax liability amounts could be scheduled against it.  For our NCL asset, we
applied a full valuation allowance.  In 2020, we generated significant taxable
income (both ordinary and capital) and we expect to generate income going
forward.  Accordingly, as of December 31, 2020, we adjusted the calculation of
the valuation allowances applied against our NOL and NCL asset.  We now apply
both the expected reversal of our deferred tax liability as well as an expected
level of income based on 2020 actual results projected forward.  The recent
improvement of our operations was the result of income earned from the
sponsorship of and investment in SPACs (mostly capital income) as well as
improving operations of our other business lines (mostly operating income). 

We


will continue to reevaluate our operations on a quarterly basis and may make
further adjustments to our valuation allowances going forward as necessary.
These adjustments could be material and could result in additional tax benefit
or tax expense.  These adjustments will only impact our deferred tax assets,
liabilities, and expense or benefit.  Our current tax expense or benefit will
not be impacted by these adjustments.



The tax benefit recognized in 2019 was comprised of a deferred tax benefit of
$678, partially offset by current tax expense of $155.  The current tax expense
incurred in 2019 was primarily the result of foreign income tax.  The deferred
tax benefit was a U.S. tax benefit, which was the result of the net loss
incurred by us in 2019.  This net loss provided additional NOLs which were
recognized as a benefit to the extent such NOLs can be scheduled against our
deferred tax liability reversal.



Net Income / (Loss) Attributable to the Non-controlling Interest





Net income / (loss) attributable to the non-controlling interest for the years
ended December 31, 2020 and 2019 was comprised of the non-controlling interest
related to member interests in the Operating LLC other than interests held by us
for the relevant periods. In addition, net income / (loss) attributable to the
non-controlling interest also included non-controlling interest related to
entities that were consolidated but not wholly owned by the Operating LLC.



SUMMARY CALCULATION OF NON-CONTROLLING INTEREST


     For the Year Ended December 31, 2020




                                                               Other                                   Cohen &
                                      Wholly Owned         Consolidated         Total Operating        Company
                                      Subsidiaries         Subsidiaries    

LLC Consolidated Inc. Consolidated Net income / (loss) before tax $ 4,951 $ 24,833

$ 29,784 $ - $ 29,784 Income tax expense / (benefit)

                   187                     -                   187          (8,856 )           (8,669 )
Net income / (loss) after tax                  4,764                24,833                29,597           8,856             38,453
Other consolidated subsidiary
non-controlling interest                           -                10,048                10,048
Net income / (loss) attributable
to the Operating LLC                           4,764                14,785                19,549
Average effective Operating LLC
non-controlling interest % (1)                                                             72.64 %
Operating LLC non-controlling
interest                                                                       $          14,200






        SUMMARY CALCULATION OF NON-CONTROLLING INTEREST
             For the Year Ended December 31, 2019




                                       Wholly Owned       Other Consolidated      Total Operating        Cohen &
                                       Subsidiaries          Subsidiaries   

LLC Consolidated Company Inc. Consolidated Net income / (loss) before tax $ (3,543 ) $

(553 ) $ (4,096 ) $ - $ (4,096 ) Income tax expense / (benefit)

                    157                      -                   157             (680 )             (523 )
Net income / (loss) after tax                  (3,700 )                 (553 )              (4,253 )            680             (3,573 )
Other consolidated subsidiary
non-controlling interest                            -                   (288 )                (288 )
Net income / (loss) attributable
to the Operating LLC                           (3,700 )                 (265 )              (3,965 )
Average effective Operating LLC
non-controlling interest % (1)                                                               31.05 %
Operating LLC non-controlling
interest                                                                         $          (1,231 )



(1) Non-controlling interest is recorded on a quarterly basis. Because earnings

are recognized unevenly throughout the year and the non-controlling interest

percentage may change during the period, the average effective

non-controlling interest percentage may not equal the percentage at the end

of any period or the simple average of the beginning and ending percentages.

The non-controlling interest percentage changed significantly in December

2019. See discussion of in kind contribution in note 4 to our consolidated


    financial statements included in this Annual Report on Form 10-K.




                                       52

--------------------------------------------------------------------------------

Table of Contents

Year Ended December 31, 2019 Compared to the Year Ended December 31, 2018

The following table sets forth information regarding our consolidated results of operations for the years ended December 31, 2019 and 2018.

COHEN & COMPANY INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
       (Dollars in Thousands)
             (Unaudited)




                                              Year Ended December 31,           Favorable / (Unfavorable)
                                               2019              2018           $ Change            % Change
Revenues
Net trading                                $     38,172       $   29,298     $         8,874               30 %
Asset management                                  7,560           12,536              (4,976 )            (40 )%
New issue and advisory                            1,831            2,979              (1,148 )            (39 )%
Principal transactions and other income           2,103            4,573              (2,470 )            (54 )%
Total revenues                                   49,666           49,386                 280                1 %

Operating expenses
Compensation and benefits                        25,972           25,385                (587 )             (2 )%
Business development, occupancy,
equipment                                         3,402            2,995                (407 )            (14 )%
Subscriptions, clearing, and execution            9,682            8,627              (1,055 )            (12 )%
Professional fee and other operating              6,251            8,459               2,208               26 %
Depreciation and amortization                       318              261                 (57 )            (22 )%
Total operating expenses                         45,625           45,727                 102                0 %

Operating income / (loss)                         4,041            3,659                 382               10 %

Non-operating income / (expense)



Interest expense, net                            (7,584 )         (8,487 )               903               11 %
Income / (loss) from equity method
affiliates                                         (553 )              -                (553 )             NM
Income / (loss) before income taxes              (4,096 )         (4,828 )               732               15 %
Income tax expense / (benefit)                     (523 )           (841 )              (318 )            (38 )%
Net income / (loss)                              (3,573 )         (3,987 )               414               10 %
Less: Net income (loss) attributable to
the non-controlling interest                     (1,519 )         (1,524 )                (5 )             (0 )%
Net income / (loss) attributable to
Cohen & Company Inc.                       $     (2,054 )     $   (2,463 )   $           409               17 %




Revenues



Revenues increased by $280, or 1% to $49,666 for the year ended December 31,
2019, as compared to $49,386 for the year ended December 31, 2018. As discussed
in more detail below, the change was comprised of (i) an increase of $8,874 in
net trading revenue; (ii) a decrease of $4,976 in asset management revenue;
(iii) a decrease of $1,148 in new issue and advisory revenue; and (iv) a
decrease of $2,470 in principal transactions and other income.



                                       53

--------------------------------------------------------------------------------


  Table of Contents



Net Trading


Net trading revenue increased by $8,874, or 30%, to $38,172 for the year ended December 31, 2019, as compared to $29,298 for the year ended December 31, 2018.

The following table shows the detail by trading group.







     NET TRADING
(Dollars in Thousands)




                                 For the Year Ended December 31,
                                2019             2018         Change
Mortgage                     $     6,780       $   5,129        1,651
Matched book repo                 12,011           4,624        7,387
High yield corporate               5,989           9,930       (3,941 )
Investment grade corporate           565           1,918       (1,353 )
Wholesale and other               12,827           7,697        5,130
Total                        $    38,172       $  29,298     $  8,874




Our net trading revenue includes unrealized gains on our trading investments as
of the applicable measurement date, which may never be realized due to changes
in market or other conditions not in our control. This may adversely affect the
ultimate value realized from these investments. In addition, our net trading
revenue also includes realized gains on certain proprietary trading positions.
Our ability to derive trading gains from such trading positions is subject to
overall market conditions. Due to volatility and uncertainty in the capital
markets, the net trading revenue recognized during any year may not be
indicative of future results. Furthermore, from time to time, some of the assets
included in the Investments-trading line of our consolidated balance sheets
represent level 3 valuations within the FASB valuation hierarchy. Level 3 assets
are carried at fair value based on estimates derived using internal valuation
models and other estimates. See notes 8 and 9 to our consolidated financial
statements included in this Annual Report on Form 10-K. The fair value estimates
determined by us may not be indicative of the final sale price at which these
assets may be sold.


We consider our matched book repo business to be subject to significant concentration risk. See note 11 to our consolidated financial statements included in Item 1 of this Annual Report on Form 10-K.





Asset Management





Asset management fees decreased by $4,976, or 40%, to $7,560 for the year ended
December 31, 2019, as compared to $12,536 for the year ended December 31, 2018,
as discussed in more detail below.





   ASSET MANAGEMENT
(Dollars in Thousands)




             For the Year Ended December 31,
           2019             2018          Change
CDOs    $    4,028       $     7,919     $ (3,891 )
Other        3,532             4,617       (1,085 )
Total   $    7,560       $    12,536     $ (4,976 )




CDOs



A substantial portion of our asset management fees are earned from the
management of CDOs. We have not completed a new securitization since 2008. As a
result, our asset management revenue has declined from its historical highs as
the assets of the CDOs decline due to maturities, repayments, auction call
redemptions, and defaults. Our ability to complete securitizations in the future
will depend upon, among other things, our asset origination capacity and
success, our ability to arrange warehouse financing to originate assets, our
willingness and capacity to fund required amounts to obtain warehouse financing
and securitized financings, and the demand in the markets for such
securitizations. The remaining portion of our AUM is from a diversified mix of
other Investment Vehicles most of which were more recently formed.



                                       54

--------------------------------------------------------------------------------

Table of Contents





Asset management revenue from Company-sponsored CDOs decreased by $3,891 to
$4,028 for the year ended December 31, 2019, as compared to $7,919 for the year
ended December 31, 2018. The following table summarizes the periods presented by
asset class.



FEES EARNED BY ASSET CLASS
  (Dollars in Thousands)




                                                For the Year Ended December 31,
                                               2019             2018         Change

TruPS and insurance company debt - U.S. $ 3,113 $ 6,594 $ (3,481 ) TruPS and insurance company debt - Europe 369

              995         (626 )
Broadly syndicated loans - Europe                  546              330          216
Total                                       $    4,028       $    7,919     $ (3,891 )

Asset management fees for TruPS and insurance company debt - U.S. declined.

In

October 2018, the Alesco II CDO had a successful auction of its assets and
liquidated.  During 2018, the Company recorded management fee revenue of $3,211
associated with the Alesco II CDO, which included $2,974 earned upon the
successful auction.  The remaining reduction in asset management fees for TruPS
and insurance company debt - U.S. was a result of average AUM declining due to
principal repayments on the assets in these securitizations.



Asset management fees for TruPS and insurance company debt - Europe declined.
In June 2018, the Dekania Europe I CDO had a successful auction of its assets
and liquidated.  During 2018, the Company recorded management fee revenue of
$435 associated with the Dekania Europe I CDO.  The remaining reduction in asset
management fees for TruPS and insurance company debt - Europe was a result a
decline in AUM due to principal repayments on the assets in these
securitizations.



Asset management fees for broadly syndicated loans - Europe consist of a single
CLO.  During August 2019, this CLO liquidated.  Of the revenue earned in 2019,
$452 represented fees earned by us upon successful liquidation.  No significant
future revenue will be earned related to this management contract.



Other



Other asset management revenue decreased by $1,085 to $3,532 for the year ended
December 31, 2019, as compared to $4,617 for the year ended December 31, 2018.
The decrease was primarily due to lower performance fees being earned on managed
accounts in 2019 as compared 2018.



New Issue and Advisory Revenue





New issue and advisory revenue decreased by $1,148, or 39%, to $1,831 for the
year ended December 31, 2019, as compared to $2,979 for the year ended December
31, 2018.



Our new issue and advisory revenue has been, and we expect it will continue to
be, volatile. We earn revenue from a limited number of engagements. Therefore, a
small change in the number of engagements can result in large fluctuations in
the revenue recognized. Further, even if the number of engagements remains
consistent, the average revenue per engagement can fluctuate considerably.
Finally, our revenue is generally earned when an underlying transaction closes
(rather than on a monthly or quarterly basis). Therefore, the timing of
underlying transactions increases the volatility of our revenue recognition.



In addition, we often incur certain costs related to new issue
engagements. These costs are included as a component of either subscriptions,
clearing and execution, or professional fees and other and will generally be
recognized in the same period that the related revenue is recognized.



                                       55

--------------------------------------------------------------------------------

Table of Contents

Principal Transactions and Other Income





Principal transactions and other income decreased by $2,470 to $2,103 for the
year ended December 31, 2019, as compared to $4,573 for the year ended December
31, 2018.




PRINCIPAL TRANSACTIONS & OTHER INCOME


       (Dollars in Thousands)




                                                    For the Year Ended December 31,
                                                   2019             2018         Change
EuroDekania                                     $      279       $      709     $   (430 )
Currency hedges                                         51               87          (36 )
CLO investments                                        258            1,456       (1,198 )
SPAC equity positions                                  116              230         (114 )
IMXI                                                   172            1,321       (1,149 )
U.S. Insurance JV                                      150               25          125
SPAC Funds                                              29               (8 )         37
Other principal investments                            465                5 

460


Total principal transactions                         1,520            3,825       (2,305 )

Star Asia revenue share                                  -              169         (169 )
IIFC revenue share                                     531              504           27
All other income / (loss)                               52               75          (23 )
Other income                                           583              748         (165 )

Total principal transactions and other income $ 2,103 $ 4,573


      (2,470 )




Principal Transactions



EuroDekania was a company that invested in hybrid capital securities of European
companies and we carried our investment at the reported NAV.  Income recognized
in each period was the result of changes in the underlying NAV of the fund as
well as distributions received.  EuroDekania sold its remaining investments and
liquidated in 2019.



Our currency hedge consisted of a Euro forward agreement designed to hedge the
currency risk primarily associated with our investment in EuroDekania.  We
terminated this hedge during 2019 and do not expect to enter into this hedge
going forward.



The CLO investments represent investments in the most junior tranche of certain
CLOs.  The average carrying value of our CLO investments for the year ended
December 31, 2019 was $2,662 as compared to $11,384 for the year ended December
31, 2018.  These investments are carried at fair value.  See note 9 to our
consolidated financial statements included in this Annual Report on Form 10-K
for information about how we determine the value of these instruments.



SPAC equity positions represents unrestricted equity investments in publicly
traded SPACs.  See note 9 to our consolidated financial statements included in
this Annual Report on Form 10-K for information about how we determine the value
of these instruments



IMXI represents unrestricted and restricted equity positions of International
Money Express, Inc. (NASDAQ: IMXI), a publicly traded company that resulted from
the merger of Intermex Holdings, LLC and FinTech Acquisition Corp. II.  See note
9 to our consolidated financial statements included in this Annual Report on
Form 10-K for information about how we determine the value of these
instruments.  Also see notes 8, 9, and 31 to our consolidated financial
statements included in this Annual Report on Form 10-K.



The U.S. Insurance JV is a company that invests in debt issued by insurance
companies and we carry our investment at its NAV.  Income recognized in each
period is the result of changes in the underlying NAV of the fund as well as
distributions received. See notes 4 and 10 to our consolidated financial
statements included in this Annual Report on Form 10-K.



The SPAC Funds primarily invest in the equity of SPACs and we carry our
investment at its reported NAV.  Income recognized in each period is the result
of changes in the underlying NAV of the SPAC Funds as well as distributions
received. See notes 4 and 9 to our consolidated financial statements included in
this Annual Report on Form 10-K.



Other Income


Other income decreased by $165 to $583 for the year ended December 31, 2019, as compared to $748 for the year ended December 31, 2018.


                                       56

--------------------------------------------------------------------------------

Table of Contents





The revenue share arrangements noted in the table above entitle us to either a
percentage of revenue earned by certain entities or a percentage of revenue
earned above certain thresholds. See discussion of revenue share arrangements in
"Item 1 - Business" beginning on page 5. These arrangements expire, or have
expired, as follows:



• The Star Asia revenue share arrangement terminated during 2018. We earned a

large incentive payment from Star Asia in the year ended December 31, 2018.

• The IIFC revenue share arrangement expires at the earlier of (i) the

dissolution of IIFC or (ii) when we have earned a cumulative $20,000 in

revenue share payments. Through December 31, 2019, we have earned $2,716 in

the aggregate. Also, in any particular year, the revenue share earned by us


     cannot exceed $2,000.




Operating Expenses



Operating expenses decreased by $102, or 0%, to $45,625 for the year ended
December 31, 2019, as compared to $45,727 for the year ended December 31, 2018.
As discussed in more detail below, the change was comprised of (i) an
increase of $587 in compensation and benefits; (ii) an increase of $407 in
business development, occupancy, and equipment; (iii) an increase of $1,055 in
subscriptions, clearing, and execution; (iv) a decrease of $2,208 in
professional fee and other operating; and (v) an increase of $57 in depreciation
and amortization.



Compensation and Benefits



Compensation and benefits increased by $587, or 2%, to $25,972 for the year
ended December 31, 2019, as compared to $25,385 for the year ended December 31,
2018.





COMPENSATION AND BENEFITS
 (Dollars in Thousands)




                                       For the Year Ended December 31,
                                     2019               2018          Change
Cash compensation and benefits   $     25,228       $     24,762     $    466
Equity-based compensation                 744                623          121
Total                            $     25,972       $     25,385     $    587




Cash compensation and benefits in the table above is primarily comprised of
salary, incentive compensation, and benefits.  Cash compensation and benefits
increased by $466 to $25,228 for the year ended December 31, 2019, as compared
to $24,762 for the year ended December 31, 2018.  Our headcount increased to 94
as of December 31, 2019 from 88 as of December 31, 2018.  Cash compensation
increased primarily due to an increase in incentive compensation related to the
increase in net trading revenue.



Equity-based compensation increased by $121 to $744 for the year ended December
31, 2019, as compared to $623 for the year ended December 31, 2018. The increase
was a result of a higher level of grants in 2019 as compared to 2018.  See note
22 to our consolidated financial statements included in this Annual Report on
Form 10-K.


Business Development, Occupancy, and Equipment





Business development, occupancy, and equipment increased by $407, or 14%, to
$3,402 for the year ended December 31, 2019, as compared to $2,995 for the year
ended December 31, 2018.  The increase was comprised of an increase in business
development of $148 and an increase in occupancy and equipment of $259.
Occupancy and equipment increased primarily due to our entry into a new office
lease for office space in New York City, which commenced in August 2018.



Subscriptions, Clearing, and Execution





Subscriptions, clearing, and execution increased by $1,055, or 12%, to
$9,682 for the year ended December 31, 2019, as compared to $8,627 for the year
ended December 31, 2018. The increase was due to increases of $326 in
subscriptions and $729 in clearing and execution.  The increase in clearing and
execution was due to increased trading volume.



                                       57

--------------------------------------------------------------------------------

Table of Contents

Professional Fee and Other Operating Expenses





Professional fee and other operating expenses decreased by $2,208, or 26%, to
$6,251 for the year ended December 31, 2019, as compared to $8,459 for the year
ended December 31, 2018. The decrease was due to decreases of $2,098 in
professional fees and $110 in other operating expense.  The professional fee
decrease was primarily the result of a reduction in consulting costs related to
new issue revenue incurred in 2019 as compared to 2018 due to less new issue
revenue earned in 2019.  In addition, in 2018, we incurred sub-advisory fees in
connection with the successful auction of the Alesco II CDO managed by DCM. No
CDOs were the subject of a successful auction during 2019.



Depreciation and Amortization





Depreciation and amortization increased by $57, or 22%, to $318 for the year
ended December 31, 2019, as compared to $261 for the year ended December 31,
2018. The increase was the result of additional leasehold improvements during
2019.


Non-Operating Income and Expense





Interest Expense, net



Interest expense, net decreased by $903, or 11%, to $7,584 for the year ended
December 31, 2019, as compared to $8,487 for the year ended December 31, 2018.





   INTEREST EXPENSE
(Dollars in Thousands)




                                                       For the Year Ended December 31,
                                                   2019               2018           Change
Junior subordinated notes                      $      3,457       $      3,499     $       (42 )
2013 Convertible Notes / 2019 Senior Notes              615                752            (137 )
2017 Convertible Note                                 1,472              1,445              27
2018 FT LOC                                             365                270              95
Redeemable Financial Instrument - DGC Trust
/ CBF                                                 1,166                587             579
Redeemable Financial Instrument - JKD
Capital Partners I LTD                                  699              1,968          (1,269 )
Redeemable Financial Instrument - ViaNova
Capital Group, LLC                                     (190 )              (34 )          (156 )
                                               $      7,584       $      8,487     $      (903 )

See notes 19 and 20 to our consolidated financial statements included in this Annual Report on Form 10-K.

Income Tax Expense / (Benefit)

Income tax expense / (benefit) was ($523) for the year ended December 31, 2019, as compared to income tax expense / (benefit) of ($841) for the year ended December 31, 2018.





The tax benefit recognized in 2019 was comprised of a deferred tax benefit of
$678 partially offset by current tax expense of $155.  The current tax expense
incurred in 2019 was primarily the result of foreign income tax.  The deferred
tax benefit was a U.S. tax benefit, which was the result of the net loss
incurred by us in 2019.  This net loss provides additional NOLs which can be
recognized as a benefit to the extent such NOLs can scheduled against our
deferred tax liability reversal.



The tax benefit recognized in 2018 was comprised of a current tax benefit of $3
and a deferred tax benefit of $838.  The deferred tax benefit was a U.S. tax
benefit which was the result of the net loss incurred by us in 2018.  This net
loss provides additional NOL carryforwards that can be recognized as a benefit
to the extent such NOLs can scheduled against our deferred tax liability
reversal.



                                       58

--------------------------------------------------------------------------------

Table of Contents

Net Income / (Loss) Attributable to the Non-controlling Interest





Net income / (loss) attributable to the non-controlling interest for the years
ended December 31, 2019 and 2018 was comprised of the non-controlling interest
related to member interests in the Operating LLC other than interests held by us
for the relevant periods. In addition, net income / (loss) attributable to the
non-controlling interest also included non-controlling interest related to
entities that were consolidated but not wholly owned by the Operating LLC.

SUMMARY CALCULATION OF NON-CONTROLLING INTEREST


     For the Year Ended December 31, 2019




                                       Wholly Owned       Other Consolidated      Total Operating        Cohen &
                                       Subsidiaries          Subsidiaries  

LLC Consolidated Company Inc. Consolidated Net income / (loss) before tax $ (3,543 ) $

(553 ) $ (4,096 ) $ - $ (4,096 ) Income tax expense / (benefit)

                    157                      -                   157             (680 )             (523 )
Net income / (loss) after tax                  (3,700 )                 (553 )              (4,253 )            680             (3,573 )
Other consolidated subsidiary
non-controlling interest                            -                   (288 )                (288 )
Net income / (loss) attributable
to the Operating LLC                           (3,700 )                 (265 )              (3,965 )
Average effective Operating LLC
non-controlling interest % (1)                                                               31.05 %
Operating LLC non-controlling
interest                                                                         $          (1,231 )







SUMMARY CALCULATION OF NON-CONTROLLING INTEREST


     For the Year Ended December 31, 2018




                                                             Other
                                      Wholly Owned        Consolidated       Total Operating        Cohen &
                                      Subsidiaries        Subsidiaries     

LLC Consolidated Company Inc. Consolidated Net income / (loss) before tax $ (4,828 ) $

            -     

$ (4,828 ) $ - $ (4,828 ) Income tax expense / (benefit)

                    25                  -                    25             (866 )             (841 )
Net income / (loss) after tax                 (4,853 )                -                (4,853 )            866             (3,987 )
Other consolidated subsidiary
non-controlling interest                           -                  -                     -
Net income / (loss) attributable
to the Operating LLC                          (4,853 )                -                (4,853 )
Average effective Operating LLC
non-controlling interest % (1)                                                          31.40 %
Operating LLC non-controlling
interest                                                                    $          (1,524 )



(1) Non-controlling interest is recorded on a quarterly basis. Because earnings

are recognized unevenly throughout the year and the non-controlling interest

percentage may change during the period, the average effective

non-controlling interest percentage may not equal the percentage at the end

of any period or the simple average of the beginning and ending percentages.








                                       59

--------------------------------------------------------------------------------

Liquidity and Capital Resources





Liquidity is a measurement of our ability to meet potential cash requirements
including ongoing commitments to repay debt borrowings, make interest payments
on outstanding borrowings, fund investments, and support other general business
purposes. In addition, our U.S. and European broker-dealer subsidiaries are
subject to certain regulatory requirements to maintain minimum levels of net
capital. Historically, our primary sources of funds have been our operating
activities and general corporate borrowings. In addition, our trading operations
have generally been financed by the use of collateralized securities financing
arrangements as well as margin loans. In recent years, we have engaged in a
number of capital raising transactions with Daniel G. Cohen, chairman of the
board and president and chief executive of European operations, and/or persons
or entities controlled by or close to Mr. Cohen because the terms of such
transactions have been more favorable than terms available from unrelated third
parties.



Certain subsidiaries of the Operating LLC have restrictions on the withdrawal of
capital and otherwise in making distributions and loans. JVB is subject to net
capital restrictions imposed by the SEC and FINRA that require certain minimum
levels of net capital to remain in this subsidiary. In addition, these
restrictions could potentially impose notice requirements or limit our ability
to withdraw capital above the required minimum amounts (excess capital) whether
through a distribution or a loan. CCFEL is regulated by the CBI and must
maintain certain minimum levels of capital. See note 25 to our consolidated
financial statements included in this Annual Report on Form 10-K.



See Liquidity and Capital Resources - Contractual Obligations below.





During the third quarter of 2010, our board of directors initiated a dividend of
$0.50 per quarter, which was paid regularly through December 31, 2011. Beginning
in 2012, our board of directors declared a dividend of $0.20 per quarter, which
was paid regularly through the first quarter of 2019.  Each time a cash dividend
was declared by our board of directors, a pro rata distribution was made to the
other members of the Operating LLC upon payment of dividends to our
stockholders.



On August 2, 2019, our board of directors announced that we have decided to
suspend our quarterly cash dividend.  We currently intend to use the related
annual cash savings to invest in new business initiatives and improve our
financial position. Any future determination to declare and pay dividends will
be made at the discretion of our board of directors, after taking into account a
variety of factors, including business, financial, and regulatory considerations
as well as any limitations under Maryland law or imposed by any agreements
governing our indebtedness. Going forward, the board of directors will re-assess
our capital resources and may or may not determine to reinstate the dividend
based on that assessment.



On December 21, 2020, August 31, 2020 and March 19, 2018, the Company entered
into letter agreements (the "December 2020 Letter Agreement", the "August 2020
Letter Agreement" and the "2018 Letter Agreement," respectively and, together,
the "10b5-1 Plan").  The December 2020 Letter Agreement and the August 2020
Letter Agreement were entered into with Piper Sandler & Co. and the 2018 Letter
Agreement was entered into with Sandler O'Neill & Partners, L.P. (which,
following a merger with Piper Jaffray, became Piper Sandler & Co. (the
"Agent")). The agreements authorized the Agent to use reasonable efforts to
purchase, on the Company's behalf, up to an aggregate purchase price of $2,000
of Common Stock on any day that the NYSE was open for business. The December
2020 Letter Agreement became effective December 23, 2020 and is in effect until
December 31,2021.  The August 2020 Letter Agreement was in effect from August
31, 2020 until August 31, 2021 or until an aggregate purchase price of $2,000
shares had been purchased, which occurred on November 10, 2020. The 2018 Letter
Agreement was in effect from March 19, 2018 until March 19, 2019. . Pursuant to
the 10b5-1 Plan, purchases of Common Stock may be made in public and private
transactions and must comply with Rule 10b-18 under the Exchange Act.  The
10b5-1 Plan was designed to comply with Rule 10b5-1 under the Exchange Act.



During the year ended December 31, 2020, we repurchased 121,181 shares in the
open market under the 10b5-1 Plan for a total purchase price of $2,143. During
the year ended December 31, 2019, we repurchased 7,890 shares in the open market
under the 10b5-1 Plan for a total purchase price of $65. During the year ended
December 31, 2018, we repurchased 57,526 shares in the open market under the
10b5-1 Plan for a total purchase price of $594.



In addition to purchases made under the 10b5-1 plan, we made the following repurchases in privately negotiated transactions during the years ended December 31, 2020, 2019, and 2018:

• During the third quarter of 2020, we purchased 42,600 shares for $746.

• During the fourth quarter of 2019, we purchased 23,000 shares of Common Stock

for $230 or $10.00 per share from a former member of the board of directors.

• During the fourth quarter of 2019, we purchased 1,000 shares of Common Stock

for $5 or $4.50 per share from the Company's chief financial officer.

• During the third quarter of 2018, we purchased 17,555 shares of Common Stock


     for $176 or $10.00 per share from a current member of the board of
     directors.



All of the repurchases noted above were completed using cash on hand.

During the years ended December 31, 2020, 2019, and 2018, we had the following other significant financing transactions. See notes 19 and 20 in our consolidated financial statements included in our Annual Report on Form 10-K:





                                       60

--------------------------------------------------------------------------------


  Table of Contents



  •  During 2020:

o We raised $5,431 by issuing equity of the Insurance SPAC III Sponsor

Entities to third parties.

o We distributed (in kind) $6,603 to the non-controlling interest holders

of the Insurance SPAC Sponsor Entities and the INSU Pipe Sponsor, LLC.

o We drew and repaid the 2019 FT Revolver in the amount of $17,500.

o We raised $4,500 in proceeds from issuance of the 2020 Senior Notes.

o We received a PPP Loan of $2,166.

o We repaid $4,386 of the 2019 Senior Notes.

o We repaid $4,777 of the LegacyTexas Credit Facility.

o We repaid $2,000 of the redeemable financial instrument with DGC Trust.


      o We repaid $2,500 of the redeemable financial instrument with CBF.
      o We repaid $421 of the ViaNova redeemable financial instruments.
      o We raised $4,556 by issuing equity of the Insurance SPAC II Sponsor
        Entities to third parties.
   •  During 2019:

o We amended and restructured the 2018 FT LOC and issued a new subordinated

revolving note, the 2019 FT Revolver.

o We amended the previously outstanding 2013 Convertible Notes, extending

the maturity date from September 25, 2019 to September 25, 2020,

increasing the interest rate from 8% to 12%, and removing the conversion


       feature. The post amendment notes are referred to as the 2019 Senior
       Notes.
     o We began periodic draws on the LegacyTexas Credit Facility totaling
       $4,777.
     o We raised an additional $1,268 from redeemable financial instruments via

an additional investment by JKD Capital Partners I on January 9, 2019. On

March 6, 2019, the agreement was amended to change the definition of
       Investment Return (as defined in the agreement).
     o Effective October 1, 2019, the DGC Trust / CBF redeemable financial
       instruments were amended and restated. The definition of Investment

Return (as defined in the agreements) was modified in both the DGC Trust

and CBF agreements. The Investment Amount was reduced by $1,500 in the

CBF agreement and the Company made a $1,500 one-time payment to CBF.

o The Insurance SPAC Sponsor Entities raised $2,550 from equity investors,

which was recorded as non-controlling interest in our consolidated

financial statements.

o The Company entered into the SPA with Daniel G. Cohen and DGC Trust

effective December 30, 2019. This transaction combined with the related

issuance of series F preferred stock resulted in an increase in

non-controlling interest of $7,779 and an increase in preferred stock of

$22. See note 4 and 31 to our consolidated financial statements included


       in this Annual Report on Form 10-K.


  •  During 2018:

o We entered into the 2018 FT LOC credit facility with Fifth Third Bank

("FT Financial").

o We repaid $1,461 of the 2013 Convertible Notes and extended the maturity

of the remaining $6,786 outstanding 2013 Convertible Notes from September

25, 2018 to September 25, 2019.

o We raised $500 in proceeds from redeemable financial instruments related

to ViaNova.

o We entered into a credit facility with LegacyTexas Bank (the "LegacyTexas


       Credit Facility") related to our ViaNova business line, which
       provided for draws up to $12,500.

o We issued the 2017 Convertible Note in an aggregate principal amount of

$15,000 to the DGC Trust.

o We raised $11,000 in proceeds from redeemable financial instruments:

$10,000 by issuing redeemable financial instruments to CBF and the DGC


       Trust; and, $1,000 in additional proceeds from the already issued
       redeemable financial instrument to JKD Capital Partners I LTD.




Cash Flows



We have seven primary uses for capital:





(1)               To fund the operations of our Capital Markets business
segment. Our Capital Markets business segment utilizes capital (i) to fund
securities inventory to facilitate client trading activities; (ii) for risk
trading for our own account; (iii) to fund our collateralized securities lending
activities; (iv) for temporary capital needs associated with underwriting
activities; (v) to fund business expansion into existing or new product lines
including additional capital dedicated to our mortgage group as well as our
matched book repo business; and (vi) to fund any operating losses incurred.



(2)               To fund the expansion of our Asset Management business
segment.  We generally grow our AUM by sponsoring new Investment Vehicles.  The
creation of a new Investment Vehicle often requires us to invest a certain
amount of our own capital to attract outside capital to manage.  Also, these new
Investment Vehicles often require warehouse and other third-party financing to
fund the acquisition of investments.  Finally, we generally will hire employees
to manage new Investment Vehicles and will operate at a loss for a startup
period.



(3)               To fund investments. We make principal investments (including
sponsor and other investments in SPACs) to generate returns.  We may need to
raise additional debt or equity financing in order to ensure we have the capital
necessary to take advantage of attractive investment opportunities.



(4)               To fund mergers or acquisitions. We may opportunistically 

use


capital to acquire other asset managers, individual asset management contracts,
or financial services firms. To the extent our liquidity sources are
insufficient to fund our future merger or acquisition activities, we may need to
raise additional funding through an equity or debt offering. No assurances can
be given that additional financing will be available in the future, or that if
available, such financing will be on favorable terms.



                                       61

--------------------------------------------------------------------------------

Table of Contents





(5)               To fund potential dividends and distributions. During the
third quarter of 2010 and for each subsequent quarter through March 31, 2019,
the board of directors declared a dividend. A pro rata distribution was paid to
the other members of the Operating LLC upon the payment of any dividends to our
stockholders.



(6)               To fund potential repurchases of Common Stock.  We have

opportunistically repurchased Common Stock in private transactions as well through the 10b5-1 Plan. See note 21 to our consolidated financial statements included in this Annual Report on Form 10-K.





(7)               To pay off debt as it matures.  We have indebtedness that 

must

be repaid as it matures. See note 20 to our consolidated financial statements included in this Annual Report on Form 10-K.





If we are unable to raise sufficient capital on economically favorable terms, we
may need to reduce the amount of capital invested for the uses described above,
which may adversely impact earnings and our ability to pay dividends.



As of December 31, 2020, and December 31, 2019, we maintained cash and cash equivalents of $41,996 and $8,304, respectively. We generated cash from or used cash for the activities described below.







SUMMARY CASH FLOW INFORMATION
   (Dollars in Thousands)




                                             Year Ended December 31,
                                         2020          2019          2018
Cash flow from operating activities    $  41,435     $ (15,463 )   $ (6,999 )
Cash flow from investing activities      (11,948 )       3,734        2,156
Cash flow from financing activities        3,789         5,936       (3,722 )
Effect of exchange rate on cash              416            (9 )       (262 )
Net cash flow                             33,692        (5,802 )     (8,827 )

Cash and cash equivalents, beginning 8,304 14,106 22,933 Cash and cash equivalents, ending $ 41,996 $ 8,304 $ 14,106






See the statements of cash flows in our consolidated financial statements. We
believe our available cash and cash equivalents, as well as our investment in
our trading portfolio and related borrowing capacity, will provide sufficient
liquidity to meet the cash needs of our ongoing operations in the near term.



2020 Cash Flows



As of December 31, 2020, our cash and cash equivalents were $41,996,
representing an increase of $33,692 from December 31, 2019. The increase was
attributable to the cash provided by operating activities of $41,435, the cash
used in investing activities of $11,948, the cash provided in financing
activities of $3,789, and the increase in cash resulting from a change in
exchange rates of $416.



The cash provided by operating activities of $41,435 was comprised of (a) net
cash inflows of $79,555 related to working capital fluctuations; (b) net cash
outflows of $47,557 from trading activities comprised of our
investments-trading, trading securities sold, not yet purchased, securities sold
under agreement to repurchase, receivables under resale agreements, and
receivables and payables from brokers, dealers, and clearing agencies, as well
as the changes in unrealized gains and losses on the investments-trading and
trading securities sold, not yet purchased; and (c) net cash inflows from other
earnings items of $9,437 (which represents net income or loss adjusted for the
following non-cash operating items: deferred taxes, other income / (expense),
realized and unrealized gains and losses on other investments at fair value,
other investments sold, not yet purchased, income / (loss) from equity method
affiliates, equity-based compensation, depreciation, impairment of goodwill, and
amortization).



The cash used in investing activities of $11,948 was comprised of (a) $62,282 in
purchases of other investments at fair value; (b) $12,519 in purchase of other
investments sold, not yet purchased; (c) $12,675 in investments in equity method
affiliates; (d) $217 in purchase of furniture, equipment, and leasehold
improvements; partially offset by (e) $54,748 in sales and returns of principal
of other investments, at fair value; (f) $20,997 in sales and returns of
principal of other investments sold, not yet purchased.



The cash provided by financing activities of $3,789 was comprised of (a) $2,166
of proceeds from the PPP loan; (b) $17,500 in draws on the FT LOC; (c) $4,500 in
proceeds from issuance of non-convertible debt; (d) $13,489 in proceeds from
issuance of non-controlling interests; partially offset by (e) $17,500 in
payments on the FT LOC; (f) $9,163 in repayment of debt; (g) $24 in debt
issuance costs; (h) $4,921 of repayments of redeemable financial instruments;
(i) $54 in cash used to net settle equity awards; (j) $35 in non-controlling
interest distributions; (k) $27 in dividends paid; and (l) $2,142 used to
purchase and retire common stock.



                                       62

--------------------------------------------------------------------------------


  Table of Contents



2019 Cash Flows



As of December 31, 2019, our cash and cash equivalents were $8,304, representing
a decrease of $5,802 from December 31, 2018. The decrease was attributable to
the cash used by operating activities of $15,463, the cash provided by investing
activities of $3,734, the cash provided by financing activities of $5,936, and
the decrease in cash resulting from a change in exchange rates of $9.



The cash used by operating activities of $15,463 was comprised of (a) net cash
outflows of $32,007 related to working capital fluctuations; (b) net cash
inflows of $19,458 from trading activities comprised of our investments-trading,
trading securities sold, not yet purchased, securities sold under agreement to
repurchase, receivables under resale agreements, and receivables and payables
from brokers, dealers, and clearing agencies, as well as the changes in
unrealized gains and losses on the investments-trading and trading securities
sold, not yet purchased; and (c) net cash outflows from other earnings items of
$2,914 (which represents net income or loss adjusted for the following non-cash
operating items: deferred taxes, other income / (expense), realized and
unrealized gains and losses on other investments, income / (loss) from equity
method affiliates, equity-based compensation, depreciation, and amortization).



The cash provided by investing activities of $3,734 was comprised of (a) $10,114
of sales and returns of principal from other investments, at fair value,
partially offset by (b) $4,352 of cash used to invest in an equity method
affiliate (see note 12 to our consolidated financial statements included in this
Annual Report on Form 10-K), (c) $101 of cash used to purchase furniture,
fixtures, and equipment, and (d) $1,927 of cash used to purchase other
investments, at fair value.



The cash provided by financing activities of $5,936 was comprised of (a) $1,268
of proceeds from redeemable financing instrument (see note 19 to our
consolidated financial statements included in this Annual Report on Form 10-K);
(b) $4,777 in proceeds from net draws on the LegacyTexas Credit Facility (see
note 20 to our consolidated financial statements included in this Annual Report
on Form 10-K); (c) $2,550 in proceeds from the issuance of non-controlling
interests; partially offset by (d) $1,500 of cash used for the partial
redemption of a redeemable financial instrument (see note 19 to our consolidated
financial statements included in this Annual Report on Form 10-K); (e) $128 of
cash used to net settle equity awards; (f) $299 of cash used to purchase and
retire Common Stock; (g) $213 of cash used for distributions to the
non-controlling interests of the Operating LLC; and (h) $519 of cash used to pay
Common Stock dividends.



2018 Cash Flows


As of December 31, 2018, our cash and cash equivalents were $14,106, representing a decrease of $8,827 from December 31, 2017. The decrease was attributable to the cash used by operating activities of $6,999, the cash provided by investing activities of $2,156, the cash used in financing activities of $3,722, and the decrease in cash resulting from a change in exchange rates of $262.





The cash used by operating activities of $6,999 was comprised of (a) net cash
outflows of $2,896 related to working capital fluctuations; (b) net cash inflows
of $2,219 from trading activities comprised of our investments-trading, trading
securities sold, not yet purchased, securities sold under agreement to
repurchase, receivables from resale agreements, and receivables and payables
from brokers, dealers, and clearing agencies, as well as the changes in
unrealized gains and losses on the investments-trading and trading securities
sold, not yet purchased; and (c) net cash outflows from other earnings items of
$6,322 (which represents net income or loss adjusted for the following non-cash
operating items: deferred taxes, other income / (expense), realized and
unrealized gains and losses on other investments, equity-based compensation,
depreciation, and amortization).



The cash provided by investing activities of $2,156 was comprised of (a) $30,023
of sales and returns of principal from other investments, at fair value,
partially offset by (b) $1,002 of cash used to purchase furniture, fixtures, and
equipment, and (c) $26,865 of cash used to purchase other investments, at fair
value.



The cash used in financing activities of $3,722 was comprised of (a) $1,461 of
cash used to repay a portion of the 2013 Convertible Notes (see note 20 to our
consolidated financial statements in this Annual Report on Form 10-K); (b) $525
of payment of debt issuance costs; (c) $75 of cash used to net settle equity
awards; (d) $769 of cash used to repurchase and retire Common Stock; (e) $426 of
distributions to the non-controlling interests of the Operating LLC; (f) $966 of
dividends to our stockholders. partially offset by (g) $500 of cash proceeds
from redeemable financial instruments (see note 19 to our consolidated financial
statements in this Annual Report on Form 10-K).



   Note Regarding Collateral Deposits and Impact on Operating Cash Flow


As part of our matched book repo operations, we enter into reverse repos with
counterparties whereby we lend money and receive securities as collateral.  In
accordance with ASC 860, the collateral securities are not recorded in our
consolidated balance sheets.  However, from time to time we will hold cash
instead of securities as collateral for these transactions.  When we are
provided cash as collateral for reverse repo transactions, we will make an entry
to increase our cash and cash equivalents and to increase our other liabilities
for the amount of cash received.  There are two main reasons we may receive
collateral in the form of cash as opposed to securities.  First, when the value
of the collateral securities we have in our possession decline, we will require
the counterparty to provide us with additional collateral.  We will accept
either cash or additional liquid securities.  Often, our counterparties will
provide us with cash as they may not have liquid securities readily available.
Second, from time to time, our counterparties require a portion of the
collateral securities in our possession returned to them for operating
purposes.  In such instances, the counterparty may not have substitute liquid
securities available and will often provide us with cash as collateral instead.
It is important to note that when we receive cash as collateral, it is temporary
in nature and we have an obligation to return that cash when the counterparty
provides substitute liquid securities as collateral or otherwise satisfies their
associated reverse repo obligation.  We are generally required to return any
cash collateral the same business day that we receive substitute securities.
The amount of cash we receive as collateral for our repo operations is volatile
and therefore, both our cash and cash equivalents balance and our cash provided
by and used in operations are volatile as they are both impacted. These amounts
can be large and should be taken into account when analyzing our cash flow from
operations.


The following table shows the impact of changes in these collateral deposits had on our cash flows in each period presented:







                                                   Year Ended December 31,
                                                 2020        2019        2018
Collateral deposit end of period               $ 41,119     $ 9,524     $ 

4,277

Less: Collateral deposit beginning of period 9,524 4,277 1,219 Impact to cash flow from operations

$ 31,595     $ 5,247     $ 3,058






                                       63

--------------------------------------------------------------------------------

Table of Contents

Regulatory Capital Requirements





We have two subsidiaries that are licensed securities dealers: JVB in the U.S.
and CCFEL in Ireland. As a U.S. broker-dealer, JVB is subject to the Uniform Net
Capital Rule in Rule 15c3-1 under the Exchange Act. Our Ireland-based
subsidiary, CCFEL, is subject to the regulatory supervision and requirements of
the CBI. The amount of net assets that these subsidiaries may distribute is
subject to restrictions under these applicable net capital rules. These
subsidiaries have historically operated in excess of minimum net capital
requirements. Our minimum capital requirements at December 31, 2020 were as
follows.




MINIMUM NET CAPITAL REQUIREMENTS


     (Dollars in Thousands)




U.S.     $ 250
Europe     707
Total    $ 957




We operate with more than the minimum regulatory capital requirement in our
licensed broker-dealers and at December 31, 2020 total net capital, or the
equivalent as defined by the relevant statutory regulations, in our licensed
broker-dealers totaled $ 68,826. See note 25 to our consolidated financial
statements included in this Annual Report on Form 10-K. In addition, our
licensed broker-dealers are generally subject to capital withdrawal notification
and restrictions.


Restrictions of Distributions of Capital from JVB





As of December 31, 2020, our total equity on a consolidated basis was
$101,437. However, the total equity of JVB was $105,785. Therefore, all of our
other subsidiaries and Cohen & Company Inc. on a stand-alone basis have an
equity deficit of $4,348.  During certain periods of time, we have generated
losses or negative cash flow outside of JVB.  We are dependent on taking
distributions of income (and potentially returns of capital) from JVB to satisfy
the cash needs as a result of the losses incurred outside of JVB or to satisfy
other obligations that come due outside of JVB. However, we are subject to
significant limitations on our ability to make distributions from JVB. These
limitations include limitations imposed by FINRA under rule 15c3-1 (described
immediately above) and limitations under our line of credit with Byline Bank
(see note 20 to our consolidated financial statements included in this Annual
Report on Form 10-K). Furthermore, counterparties to JVB have their own internal
counterparty credit requirements. The specific requirements are not generally
shared with us. However, if we take too much in capital distributions from JVB
(beyond its net income), we may not be able to trade with certain counterparties
which may cause JVB's operations to deteriorate.



Securities Financing



We maintain repurchase agreements with various third-party financial
institutions. There is no maximum limit as to the amount of securities that may
be transferred pursuant to these agreements, and transactions are approved on a
case-by-case basis. The repurchase agreements do not include substantive
provisions other than those covenants and other customary provisions contained
in standard master repurchase agreements. The repurchase agreements generally
require us to transfer additional securities to the counterparty in the event
the value of the securities then held by the counterparty in the margin account
falls below specified levels and contain events of default were we to breach our
obligations under the agreement. We receive margin calls from our repurchase
agreement counterparties from time to time in the ordinary course of business.
To date, we have maintained sufficient liquidity to meet margin calls, and we
have never been unable to satisfy a margin call, however, no assurance can be
given that we will be able to satisfy requests from our counterparties to post
additional collateral in the future. See note 11 to our consolidated financial
statements included in this Annual Report on Form 10-K.



If there were an event of default under a repurchase agreement, the counterparty
would have the option to terminate all repurchase transactions existing with us
and make any amount due from us to the counterparty payable immediately.
Repurchase obligations are full recourse obligations to us. If we were to
default under a repurchase obligation, the counterparty would have recourse to
our other assets if the collateral was not sufficient to satisfy our obligations
in full. Most of our repurchase agreements are entered into as part of our
matched book repo business.



Our clearing brokers provide securities financing arrangements including margin
arrangements and securities borrowing and lending arrangements. These
arrangements generally require us to transfer additional securities or cash to
the clearing broker in the event the value of the securities then held by the
clearing broker in the margin account falls below specified levels and contain
events of default were we to breach our obligations under such agreements.



An event of default under the clearing agreement would give the counterparty the
option to terminate the clearing arrangement. Any amounts owed to the clearing
broker would be immediately due and payable. These obligations are recourse to
us. Furthermore, a termination of any of our clearing arrangements would result
in a significant disruption to our business and would have a significant
negative impact on our dealings and relationship with our customers.



                                       64

--------------------------------------------------------------------------------

Table of Contents





The following table presents our period end balance, average monthly balance,
and maximum balance at any month end for receivables under resale agreements and
securities sold under agreements to repurchase.



                                                           For the Twelve      For the Twelve
                                                            Months Ended        Months Ended
                                                            December 31,        December 31,
                                                                2020                2019
Receivables under resale agreements
Period end                                                 $     5,716,343     $     7,500,002
Monthly average                                            $     6,461,534           6,458,757
Maximum month end                                          $     8,945,403           7,500,002
Securities sold under agreements to repurchase
Period end                                                 $     5,713,212     $     7,534,443
Monthly average                                            $     6,486,137           6,501,691
Maximum month end                                          $     8,960,197           7,534,443




Fluctuations in the balance of our repurchase agreements from period to period
and intraperiod are dependent on business activity in those periods. The
fluctuations in the balances of our receivables under resale agreements over the
periods presented were impacted by our clients' desires to execute
collateralized financing arrangements through the repurchase market or other
financing products.


Average balances and period end balances will fluctuate based on market and liquidity conditions and we consider such intraperiod fluctuations as typical for the repurchase market. Month-end balances may be higher or lower than average period balances.





Debt Financing



The following table summarizes our long-term indebtedness and other financing
outstanding. See note 20 to our consolidated financial statements in our Annual
Report on Form 10-K for more information.





    DETAIL OF DEBT
(Dollars in Thousands)




                                    As of December 31,
                                                             Interest
Description                         2020          2019      Rate Terms   Interest (4)        Maturity
Non-convertible debt:
12.00% senior notes (the "2020
Senior Notes")                    $   4,500     $       -     Fixed              12.00 %   January 2022
12.00% senior notes (the "2019                                                               September
Senior Notes")                        2,400         6,786     Fixed              12.00 %     2021 (1)
PPP Loan                              2,166             -     Fixed               1.00 %     May 2022
Contingent convertible debt:
8.00% convertible senior note                                                               March 2022

(the "2017 Convertible Note") 15,000 15,000 Fixed

       8.00 %        (2)
Less unamortized debt issuance
costs                                  (401 )        (703 )
                                     14,599        14,297
Junior subordinated notes (3):
Alesco Capital Trust I               28,125        28,125    Variable             4.21 %     July 2037
Sunset Financial Statutory
Trust I                              20,000        20,000    Variable             4.37 %    March 2035
Less unamortized discount           (24,690 )     (25,124 )
                                     23,435        23,001

ByLine Bank                               -             -    Variable              N/A     October 2021
FT Financial Bank, N.A. Credit
Facility                                  -             -    Variable              N/A               N/A

LegacyTexas Credit Facility               -         4,777    Variable              N/A               N/A
Total                             $  47,100     $  48,861

(1) On September 25, 2019, we amended and restated the previously outstanding

2013 Convertible Notes, which were scheduled to mature September 25,

2019. The material terms and conditions of the 2013 Convertible Notes

remained substantially the same, except that (i) the maturity date thereof

changed from September 25, 2019 to September 25, 2020; (ii) the conversion

feature in the 2013 Convertible Notes was removed; (iii) the interest rate

thereunder changed from 8% per annum (9% in the event of certain events of

default) to 12% per annum (13% in the event of certain events of default);

and (iv) the restrictions regarding prepayment were removed. The

post-amendment notes are referred to herein as the "2019 Senior Notes" and

the pre-amendment notes are referred to herein as the "2013 Convertible

Notes." On September 25, 2020, the 2019 Senior Notes were amended again to

extend the maturity date from September 25, 2020 to September 25, 2021.






                                       65

--------------------------------------------------------------------------------


  Table of Contents


(2) The holder of the 2017 Convertible Note may convert all or any part of the

outstanding principal amount at any time prior to maturity into units of the

Operating LLC at a conversion price of $1.45 per unit, subject to customary

anti-dilution adjustments. Units of the membership interests of Operating

LLC not held by Cohen & Company Inc. may, with certain restrictions, be

redeemed and exchanged into shares of Common Stock on a ten-for-one

basis. Therefore, the 2017 Convertible Note can be converted into Operating

LLC units of membership interests and then redeemed and exchanged into

Common Stock at an effective conversion price of $14.50.

(3) The junior subordinated notes listed represent debt the Company owes to the

two trusts noted above. The total par amount owed by the Company to the

trusts is $49,614. However, the Company owns the common stock of the trusts

in a total par amount of $1,489. The Company pays interest (and at maturity,

principal) to the trusts on the entire $49,614 junior notes outstanding.

However, the Company receives back from the trusts the pro rata share of

interest and principal on the common stock held by the Company. These trusts

are variable interest entities ("VIEs") and the Company does not consolidate

them even though the Company holds the common stock. The Company carries the

common stock on its balance sheet at a value of $0. The junior subordinated

notes are recorded at a discount to par. When factoring in the discount, the

yield to maturity of the junior subordinated notes as of December 31,

2020 on a combined basis is 11.58% assuming the variable rate in effect on

the last day of the reporting period remains in effect until maturity.

(4) Represents the interest rate in effect as of the last day of the reporting


      period.



Redeemable Financial Instruments





As of December 31, 2020, we have the following sources of financing, which we
account for as redeemable financial instruments. See note 19 to our consolidated
financial statements included in this Annual Report on Form 10-K.  Subsequent to
December 31, 2020, we have notice to CBF that we intent to redeem the remining
$4,000 outstanding on or around March 31, 2021.





    REDEEMABLE FINANCIAL INSTRUMENTS
         (Dollars in thousands)






                               As of December 31,
                                2020          2019
JKD Investor                 $    7,957     $  7,957
DGC Trust / CBF                   4,000        8,500
ViaNova Capital Group, LLC            -          526
                             $   11,957     $ 16,983

Off-Balance Sheet Arrangements





Other than as described in note 10 (derivative financial instruments) and note
18 (variable interest entities) to our consolidated financial statements
included in this Annual Report on Form 10-K, there were no material off balance
sheet arrangements as of December 31, 2020.



                                       66

--------------------------------------------------------------------------------


  Table of Contents



Contractual Obligations



The table below summarizes our significant contractual obligations as of
December 31, 2020 and the future periods in which such obligations are expected
to be settled in cash. Our junior subordinated notes are assumed to be repaid on
their respective maturity dates. Also, we have assumed that the 2017 Convertible
Note is not converted prior to maturity. Excluded from the table are obligations
that are short-term in nature, including trading liabilities and repurchase
agreements. In addition, amortization of discount on debt is excluded.







        CONTRACTUAL OBLIGATIONS
           December 31, 2020
        (Dollars in Thousands)




                                                              Payment Due by Period
                                                 Less than 1                                         More than 5
                                    Total           Year          1 - 3 Years       3 - 5 Years         Years
Operating lease arrangements      $    8,826     $     1,398     $       2,279     $       2,037     $     3,112
Maturity of 2020 Senior Notes          4,500               -             4,500                 -               -
Interest on 2020 Senior Notes            586             540                46                 -               -
Maturity of 2019 Senior Note           2,400           2,400                 -                 -               -
Interest on 2019 Senior Note             211             211                 -                 -               -
Maturity of 2017 Convertible
Note (1)                              15,000               -            15,000                 -               -
Interest on 2017 Convertible
Note (1)                               1,427           1,200               227                 -               -
Maturities on junior
subordinated notes                    48,125               -                 -                 -          48,125
Interest on junior subordinated
notes (2)                             32,319           2,060             4,120             6,180          19,959
Redeemable Financial Instrument
- JKD Capital Partners 1 (3)           7,957           7,957                 -                 -               -
Redeemable Financial Instrument
- CBF (3)                              4,000           4,000                 -                 -               -
Other Operating Obligations (4)        2,933           1,713             1,172                48               -
                                    $128,284         $21,479           $27,344            $8,265         $71,196

(1) Assumes the 2017 Convertible Note is not converted prior to maturity.

The

holder of the Convertible Note has control over whether or not the

convertible note is paid off in cash or converted into equity. If it is

converted into equity, no cash outflow will be required.

(2) The interest on the junior subordinated notes related to Alesco Capital

Trust I is variable. The interest rate of 4.21% (based on a 90-day LIBOR

rate in effect as of December 31, 2020 plus 4.00%) was used to compute the


      contractual interest payment in each period noted. The interest on the
      junior subordinated notes related to Sunset Financial Statutory Trust I is

variable. The interest rate of 4.37% (based on a 90-day LIBOR rate in effect

as of December 31, 2020 plus 4.15%) was used to compute the contractual

interest payment in each period noted.

(3) Represents redemption value of the redeemable financial instruments as of

the reporting period. The redeemable financial instruments do not have a

fixed maturity date. The period shown above represents the first period the

holder of these instruments has the ability to require redemption by us.


  (4) Represents material operating contracts for various services.




We believe that we will be able to continue to fund our current operations and
meet our contractual obligations through a combination of existing cash
resources and other sources of credit. Due to the uncertainties that exist in
the economy, we cannot be certain that we will be able to replace existing
financing or find sources of additional financing in the future.



Critical Accounting Policies and Estimates





Our accounting policies are essential to understanding and interpreting the
financial results in our consolidated financial statements. Our industry is
subject to a number of highly complex accounting rules and requirements many of
which place heavy burdens on management to make judgments relating to our
business. We encourage readers of this Form 10-K to read all of our critical
accounting policies, which are included in note 3 to our consolidated financial
statements included herein for a full understanding of these issues and how the
financial statements are impacted by these judgments. Certain of these policies
are considered to be particularly important to the presentation of our financial
results because they require us to make assumptions and estimates about future
events and apply judgments that affect the reported amounts of assets,
liabilities, revenues, expenses, and the related disclosures. We base our
assumptions, estimates, and judgments on historical experience, current trends,
and other factors that management believes to be relevant at the time our
consolidated financial statements are prepared. On a regular basis, management
reviews the accounting policies, assumptions, estimates, and judgments to ensure
that our financial statements are presented fairly and in accordance with U.S.
GAAP. However, because future events and their effects cannot be determined with
certainty, actual results could differ from our assumptions and estimates, and
such differences could be material.



                                       67

--------------------------------------------------------------------------------

Table of Contents





 We consider the accounting policies discussed below to be the policies that are
the most impactful to our financial statements and also subject to significant
management judgment.


Valuation of Financial Instruments

How fair value determinations impact our financial statements





All of the securities we own that are classified as investments-trading,
securities sold, not yet purchased, other investments, at fair value, or other
investments sold, not yet purchased are recorded at fair value with changes in
fair value (both unrealized and realized) recorded in earnings.



Unrealized and realized gains and losses on securities classified as
investments-trading and securities sold, not yet purchased in the consolidated
balance sheets are recorded as a component of net trading revenue in the
consolidated statements of operations. Unrealized and realized gains and losses
on securities classified as other investments, at fair value, and other
investments sold, not yet purchased in the consolidated balance sheets are
recorded as a component of principal transactions and other income in the
consolidated statements of operations.



How we determine fair value for securities





We account for our investment securities at fair value under various accounting
literature, including Financial Accounting Standards Board ("FASB") Accounting
Standards Codification ("ASC") 320, Investments - Debt and Equity Securities
("ASC 320"), pertaining to investments in debt and equity securities and the
fair value option of financial instruments in ASC 825, Financial Instruments
("ASC 825"). We also account for certain assets at fair value under applicable
industry guidance such as: (a) FASB ASC 946, Financial Services-Investment
Companies ("ASC 946"); and (b) FASB ASC 940-320, Proprietary Trading Securities
("ASC 940-320").



The determination of fair value is based on quoted market prices of an active
exchange, independent broker market quotations, market price quotations from
third-party pricing services, or, when independent broker quotations or market
price quotations from third-party pricing services are unavailable, valuation
models prepared by management. These models include estimates and the valuations
derived from them could differ materially from amounts realizable in an open
market exchange.



We adopted the fair value measurement provisions in ASC 820, Fair Value
Measurements and Disclosures ("ASC 820"), applicable to financial assets and
financial liabilities effective January 1, 2008. ASC 820 defines fair value as
the price that would be received to sell the asset or paid to transfer the
liability between market participants at the measurement date ("exit price"). An
exit price valuation will include margins for risk even if they are not
observable. In accordance with ASC 820, we categorize our financial instruments,
based on the priority of the inputs to the valuation technique, into a
three-level valuation hierarchy. The hierarchy gives the highest priority to
unadjusted quoted prices in active markets for identical assets or liabilities
(level 1 measurements) and the lowest priority to unobservable inputs (level 3
measurements). The three levels of the hierarchy under ASC 820 are described
below.


Level 1 Financial assets and liabilities whose values are based on unadjusted

quoted prices in active markets that are accessible at the measurement

date for identical, unrestricted assets or liabilities.

Level 2 Financial assets and liabilities whose values are based on one or more of


        the following: (a) quoted prices for similar assets or liabilities in
        active markets; (b) quoted prices for identical or similar assets or
        liabilities in non-active markets; (c) pricing models whose inputs are

observable for substantially the full term of the asset or liability; or

(d) pricing models whose inputs are derived principally from or

corroborated by observable market data through correlation or other means

for substantially the full term of the asset or liability.

Level 3 Financial assets and liabilities whose values are based on prices or

valuation techniques that require inputs that are both significant to the

fair value measurement and unobservable. These inputs reflect

management's own assumptions about the assumptions a market participant


        would use in pricing the asset or liability.




In certain cases, the inputs used to measure fair value may fall into different
levels of the valuation hierarchy. In such cases, the level of the valuation
hierarchy within which the fair value measurement in its entirety falls has been
determined based on the lowest level input that is significant to the fair value
measurement in its entirety. Our assessment of the significance of a particular
input to the fair value measurement in its entirety requires judgment and
considers factors specific to the asset or liability.



                                       68

--------------------------------------------------------------------------------

Table of Contents





Financial instruments carried at contract amounts with short-term maturities
(one year or less) are repriced frequently or bear market interest rates.
Accordingly, those contracts are carried at amounts approximating fair value.
Financial instruments carried at contract amounts on our consolidated balance
sheets include receivables from and payables to brokers, securities purchased
under agreements to resell ("reverse repurchase agreements" or "receivables
under resale agreements"), and sales of securities under agreements to
repurchase ("repurchase agreements").



How we determine fair value for investments in investment funds and similar vehicles





A portion of our other investments, at fair value represents investments in
investment funds and other non-publicly traded entities that have the attributes
of investment companies as described in ASC 946-15-2. We estimate the fair value
of these entities using the reported net asset value per share as of the
reporting date in accordance with the "practical expedient" provisions related
to investments in certain entities that calculated net asset value per share (or
its equivalent) included in ASC 820.



Derivative Financial Instruments

We do not utilize hedge accounting for our derivatives. Accordingly, all derivatives are carried at fair value with unrealized and realized gains recognized in earnings.





If the derivative is expected to be managed by employees of our Capital Markets
business segment or is a hedge for an investment classified as
investments-trading, the derivative will be carried as a component of
investments-trading if it is an asset or securities sold, not yet purchased if a
liability. If the derivative is a hedge for an investment carried as a component
of other investments, at fair value, the derivative will be recorded in other
investments, at fair value if it is an asset or other investments sold, not yet
purchase if it is a liability.



We may, from time to time, enter into derivatives to manage our risk exposures
arising from (i) fluctuations in foreign currency rates with respect to our
investments in foreign currency denominated investments; (ii) our investments in
interest sensitive investments; (iii) our investments in various equity
instruments; and (iv) our facilitation of mortgage-backed trading. Derivatives
entered into by us, from time to time, may include (i) foreign currency forward
contracts; (ii) purchase and sale agreements of TBAs and other forward agency
MBS contracts; (iii) other extended settlement trades; and (iv) equity options
such as calls and puts.



TBAs are forward contracts to purchase or sell mortgage-backed securities whose
collateral remain "to be announced" until just prior to the trade settlement. In
addition to TBAs, we sometimes enter into forward purchases or sales of agency
mortgage-backed securities where the underlying collateral has been
identified. These transactions are referred to as other forward agency MBS
contracts. We account for TBAs and other forward agency MBS contracts as
derivatives.



In addition to TBAs and other forward agency MBS contracts as part of our
broker-dealer operations, we may from time to time enter into other securities
or loan trades that do not settle within the normal securities settlement
period. In those cases, the purchase or sale of the security or loan is not
recorded until the settlement date. However, from the trade date until the
settlement date, our interest in the security is accounted for as a derivative
as either a forward purchase commitment or forward sale commitment.



Derivatives involve varying degrees of off-balance sheet risk, whereby changes
in the level or volatility of interest rates or market values of the underlying
financial instruments may result in changes in the value of a particular
financial instrument in excess of its carrying amount. Depending on our
investment strategy, realized and unrealized gains and losses are recognized in
principal transactions and other income or in net trading in our consolidated
statements of operations on a trade date basis.



Accounting for Income Taxes





We account for income taxes under the asset and liability method, which requires
the recognition of deferred tax assets and liabilities for the expected future
tax consequences of events that have been included in the financial statements.
Under this method, deferred tax assets and liabilities are determined based on
the differences between the financial statements and tax basis of assets and
liabilities using enacted tax rates in effect for the year in which the
differences are expected to reverse. The effect of a change in tax rates on
deferred tax assets and liabilities is recognized in income in the period that
includes the enactment date.



We record net deferred tax assets to the extent we believe these assets will
more likely than not be realized. In making such a determination, we consider
all available positive and negative evidence, including scheduled reversals of
deferred tax liabilities, projected future taxable income, tax planning
strategies, and recent financial operations. In the event we were to determine
that we would be able to realize our deferred income tax assets in the future in
excess of their net recorded amount, we would make an adjustment to the
valuation allowance, which would reduce the provision for income taxes.



Our policy is to record penalties and interest as a component of provision for income taxes in our consolidated statements of operations.


                                       69

--------------------------------------------------------------------------------

Table of Contents





Our voting-controlled subsidiary, the Operating LLC, is treated as a
pass-through entity for U.S. federal income tax purposes and in most of the
states in which we do business. The Operating LLC is subject to entity level
taxes in certain state and foreign jurisdictions. However, as a result of the
AFN Merger, we acquired significant deferred tax assets and liabilities and now
have significant tax attributes. Effective as of January 1, 2010, we began to be
treated as a C corporation for U.S. federal and state income tax purposes.



As shown in note 23 to the consolidated financial statements contained herein,
we currently have significant recognized as well as unrecognized deferred tax
assets. Deferred tax assets should only be recognized to the extent that we
determine we can benefit in the future from the asset.  Generally, this
determination is based on our estimates of our ability to generate future
taxable income.  This determination is complex and subject to judgment. The
determination is ongoing and subject to change. If we were to change this
determination in the future, a significant deferred tax benefit or deferred tax
expense would be recognized as a component of earnings.



Revenue Recognition



Net trading



Net trading includes: (i) all gains, losses, interest income, dividend income,
and interest expense from securities classified as investments-trading and
trading securities sold, not yet purchased; (ii) interest income and expense
from collateralized securities transactions; and (iii) commissions and riskless
trading profits. Net trading is reduced by margin interest, which is recorded on
an accrual basis.  We refer to investments included as a component of
investments - trading and trading securities sold, not yet purchased as trading
assets.



Riskless trades are transacted through our proprietary account with a customer
order in hand, resulting in little or no market risk to us. Transactions that
settle in the regular way are recognized on a trade date basis. Extended
settlement transactions are recognized on a settlement date basis (although in
cases of extended settlement trades, the unsettled trade is accounted for as a
derivative between trade and settlement date). See notes 3 and 10 to our
consolidated financial statements included in this Annual Report on Form
10-K. The investments classified as trading are carried at fair value. The
determination of fair value is based on quoted market prices of an active
exchange, independent broker market quotations, market price quotations from
third-party pricing services or, when independent broker quotations or market
price quotations from third-party pricing services are unavailable, valuation
models prepared by our management. The models include estimates, and the
valuations derived from them could differ materially from amounts realizable in
an open market exchange. See note 9 to our consolidated financial statements
included in this Annual Report on Form 10-K.



Asset management


Asset management revenue consists of management fees earned from Investment Vehicles. In the case of CDOs, the fees earned by us generally consist of senior, subordinated, and incentive fees.

The senior asset management fee is generally senior to all the securities in the CDO capital structure and is recognized on a monthly basis as services are performed. The senior asset management fee is generally paid on a quarterly basis.





The subordinated asset management fee is an additional payment for the same
services but has a lower priority in the CDO cash flows. If the CDO experiences
a certain level of asset defaults and deferrals, these fees may not be paid.
There is no recovery by the CDO of previously paid subordinated asset management
fees. It is our policy to recognize these fees on a monthly basis as services
are performed. The subordinated asset management fee is generally paid on a
quarterly basis. However, if we determine that the subordinated asset management
fee will not be paid (which generally occurs on the quarterly payment date), we
will stop recognizing additional subordinated asset management fees on that
particular CDO and will reverse any subordinated asset management fees that are
accrued and unpaid. We will begin accruing the subordinated asset management fee
again if payment resumes and, in management's estimate, continued payment is
reasonably assured. If payment were to resume but we were unsure of continued
payment, we would recognize the subordinated asset management fee as payments
were received and would not accrue such fees on a monthly basis.



The incentive management fee is an additional payment, made typically after five
to seven years of the life of a CDO, which is based on the clearance of an
accumulated cash return on investment ("Hurdle Return") received by the most
junior CDO securities holders. It is an incentive for us to perform in our role
as asset manager by minimizing defaults and maximizing recoveries. The incentive
management fee is not ultimately determined or payable until the achievement of
the Hurdle Return by the most junior CDO securities holders. We recognize
incentive fee revenue when it is probable and there is not a significant chance
of reversal in the future.



In the case of Investment Vehicles other than CDOs, generally we earn a base fee
and, in some cases, also earns an incentive fee. Base fees will generally be
recognized monthly as services are performed and will be paid monthly or
quarterly. The contractual terms of each arrangement will determine our revenue
recognition policy for incentive fees in each case. However, in all cases, we
recognize the incentive fees when they are probable and there is not a
significant chance of reversal in the future.



                                       70

--------------------------------------------------------------------------------


  Table of Contents



New issue and advisory


New issue and advisory revenue include: (i) new issue revenue associated with originating, arranging, or placing newly created financial instruments and (ii) revenue from advisory services. New issue and advisory revenue is recognized when all services have been provided and payment is earned.

Principal transactions and other income





Principal transactions include all gains, losses, and income (interest and
dividend) from financial instruments classified as other investments, at fair
value and other investments sold, not yet purchased in the consolidated balance
sheets.  We refer to investments included as a component of other investments,
at fair value and other investments sold, not yet purchased as our principal
investing assets.



The investments classified as other investments, at fair value and other
investments sold, not yet purchased are carried at fair value. The determination
of fair value is based on quoted market prices of an active exchange,
independent broker market quotations, market price quotations or models from
third-party pricing services, or, when independent broker quotations or market
price quotations or models from third-party pricing services are unavailable,
valuation models prepared by management. These models include estimates, and the
valuations derived from them could differ materially from amounts realizable in
an open market exchange. Dividend income is recognized on the ex-dividend date.



Other income / (loss) includes foreign currency gains and losses, interest earned on cash and cash equivalents, interest earned and losses incurred on notes receivable, and other miscellaneous income including revenue from revenue sharing arrangements.





Variable Interest Entities



FASB ASC 810, Consolidation ("ASC 810") contains the guidance surrounding the
definition of VIEs, the definition of variable interests, and the consolidation
rules surrounding VIEs. In general, VIEs are entities in which equity investors
lack the characteristics of a controlling financial interest or do not have
sufficient equity at risk for the entity to finance its activities without
additional subordinated financial support. As a general matter, a reporting
entity must consolidate a VIE when it is deemed to be the primary
beneficiary. The primary beneficiary is the entity that has both (a) the power
to direct the matters that most significantly impact the VIE's financial
performance and (b) a significant variable interest in the VIE.



We can potentially become involved with a VIE in three main ways:

Our Principal Investing Portfolio

For each investment made within the principal investing portfolio, we assess whether the investee is a VIE and if we are the primary beneficiary. If we determine the entity is a VIE and we are the primary beneficiary, we will consolidate it.

Our Asset Management Activities





For each investment management contract, we enter into, we will assess whether
the entity being managed is a VIE and if we are the primary beneficiary. If we
determine the entity is a VIE and we are the primary beneficiary, we will
consolidate it.



Our Trading Portfolio



From time to time, we may have an interest in a VIE through the investments we
make as part of our trading activities. Because of the high volume of trading
activity in which we engage, we do not perform a formal assessment of each
individual investment within our trading portfolio to determine if the investee
is a VIE and if we are the primary beneficiary. Even if we were to obtain a
variable interest in a VIE through our trading portfolio, we would not be deemed
to be the primary beneficiary for two main reasons: (a) we do not usually obtain
the power to direct activities that most significantly impact any investee's
financial performance and (b) a scope exception exists within the consolidation
guidance for cases where the reporting entity is a broker-dealer and any control
(either as the primary beneficiary of a VIE or through a controlling interest in
a voting interest entity) was deemed to be temporary. In the unlikely case that
we obtained the power to direct activities and obtained a significant variable
interest in an investee in our trading portfolio that was a VIE, any such
control would be deemed to be temporary due to the rapid turnover within the
trading portfolio.



Stock Compensation


We account for stock compensation according to FASB ASC 718, Stock Compensation ("ASC 718"). In the periods presented herein, we have had three different types of grants that fall under ASC 718.





First, we sometimes grant to employees and directors restricted common stock in
Cohen & Company Inc.  These grants vest over a period of time and only have
service based vesting criteria.  In these cases, we determine the fair value of
the grants by taking the closing stock price of Cohen & Company Inc. on the
grant date and multiplying it by the number of restricted shares granted.  The
recipient is entitled to dividends during the vesting period but they are paid
only if (and to the extent) the restricted share grant ultimately vests.  We
recognize the expense over the service period on a straight-line basis.  We
assume no forfeitures up front and record forfeitures as they occur by reducing
expense.



Second, we sometimes grant to employees operating units of the Operating LLC.
These grants also vest over a period of time and only have service based vesting
criteria.  Because there is a fixed exchange ratio between units of the
Operating LLC and shares of Cohen & Company Inc., the fair value of the grant is
calculated by taking the closing stock price of Cohen & Company Inc. on the
grant date, adjusting for the exchange ratio, and then multiplying by the number
of units of the Operating LLC granted.  The recipient is entitled to
distributions during the vesting period but they are paid only if (and to the
extent) the unit grant ultimately vests.  We recognize the expense over the
service period on a straight-line basis.  We assume no forfeitures up front and
record forfeitures as they occur by reducing expense.



                                       71
--------------------------------------------------------------------------------


Third, employees sometimes invest in the membership interests of consolidated
SPAC sponsor entities (the Insurance SPAC Sponsor Entities, the Insurance SPAC
II Sponsor Entities, and the Insurance SPAC III Sponsor Entities).  Because
these entities are consolidated and the employees are investing in the
consolidated company's non-controlling interest, these equity interests fall
under ASC 718.  Generally, the employee invests a de-minimus amount and receives
an allocation of the founders shares held by the sponsor entity.  The investment
does not have any explicit vesting criteria associated with it.  Generally, the
employee's investment will be worthless if the SPAC is liquidated and it will
become worth something if the SPAC completes its business combination.
Therefore, we treat these grants as having a performance condition (i.e. the
completion of the SPAC business combination).  Further, at the time of the
investments, we treat this performance condition as being non-probable.  The
effect of this is that we record no expense related to these investments until
(and only if) the business combination is completed.  Upon completion of the
business combination, we record compensation expense in an amount equal to the
fair value of the grant.  The fair value of the grant is equal to the public
trading price of the SPAC on the date of the grant adjusted for certain sale
restrictions imposed on the shares the employee receives (generally, they are
restricted for sale for some time period and subject to certain hurdle prices
before they become freely tradeable).  We use a Monte Carlo simulation model to
determine the appropriate discount to place on shares that are subject to hurdle
prices.  The compensation amount is recorded with an offsetting credit to
non-controlling interest.  From that point forward, the shares received by
the employee are treated as part of the non-controlling interest and allocated
income, expense, gains, and losses accordingly until the applicable sponsor
entity is liquidated or otherwise de-consolidated.



Investments in Special Purpose Acquisition Companies ("SPACs") Sponsor Entities





We invest in the sponsor entities of SPACs.  The sponsor entities are limited
liability companies (each an "LLC") that pool their members' interests and
invest in the private placement and founders shares (together, sponsor shares)
of a SPAC.  The SPAC will also raise funds in a public offering and seek to
complete a business combination within an agreed upon time frame.  The SPAC will
use the proceeds raised from the sponsor shares to pay transaction and operating
expenses during the period it is seeking a business combination.  The proceeds
of the public offering are placed in an interest bearing trust and can only be
used to complete the business combination and pay taxes on the interest earned.
Generally, the public investors must approve any business combination prior to
its effectiveness.  If a business combination is not completed within the agreed
upon time frame, the SPAC will liquidate and return the public
investors' investment to them.  If there are funds remaining after liquidation,
the sponsor entities may receive some portion of their investment back, but
likely they will suffer a total loss of their investment.  If the business
combination is completed, the sponsor entities private placement in the SPAC
will entitle them to a combination of unrestricted common, restricted common,
and (in some cases) warrants of the post-business combination SPAC (which is a
publicly traded company).  The following summarizes our accounting policies
related to our investments in these entities:



• The sponsor entities are LLCs that give all important decision making rights to

their respective managing member. Furthermore, the other members of the LLC

can not replace the managing member. Accordingly, we have concluded that the

sponsor entities are VIEs and the managing member has the power to direct its

most important economic activities. In all cases where we are the managing

member of a sponsor entity, we also have had a significant economic interest in

such sponsor entity and therefore consolidate such sponsor entity. • In all cases where we have consolidated a sponsor entity, we have determined

that the sponsor entity's private placement investment in the SPAC which it

sponsors should be treated as an equity method investment during the SPAC's

pre-business combination period. Furthermore, because of the difficulty of

determining the fair value of such an investment in the SPAC's pre-business

combination period, we have chosen to not elect fair value option. • If a SPAC completes its business combination, the sponsor entity's investment

in the SPAC will be converted to a combination of unrestricted and restricted

shares in the post-business combination SPAC. At this point (assuming we

consolidate the sponsor entity), we will account for the shares received at

fair value. We will reclassify any remaining equity method investment balance

to other investments, at fair value and record principal transactions income

for the difference. We will record non-controlling interest expense for the

SPAC shares that are distributable to the non-controlling interest holders of

the sponsor entity. The fair value of the unrestricted shares received is equal

to the public trading price of the SPAC on the date of the business

combination. The fair value of the restricted shares received is adjusted

downwards from the public trading price for certain sale restrictions imposed

(generally, they are restricted for sale for some time period and subject to

certain hurdle prices before they become freely tradeable). We use a Monte

Carlo simulation model to determine the appropriate discount to place on shares

that are subject to hurdle prices. In the case of a SPAC business combination

where we consolidate the sponsor entity, generally there is also an

equity-based compensation entry to be recorded at the date of the business

combination. See equity-based compensation section above. We will continue to

mark the sponsor entity's investment in the SPAC to market and record principal

transactions income or loss and offsetting non-controlling interest income or

expense until the sponsor entity itself distributes all of the SPAC shares it

owns to its members and liquidates. At that point, we will hold the SPAC

shares directly (rather than through a consolidated subsidiary) and will record

principal transaction income and loss until the SPAC shares themselves are

liquidated.

• We will also invest in sponsor entities that we do not consolidate because we

are not the managing member of such sponsor entity or otherwise do not

otherwise have the power to direct the sponsor entity's most important

activities. In these cases, we treat our investment in the sponsor entity as

an equity method investment. Furthermore, because of the difficulty of

determining the fair value of such an investment in the applicable SPAC's

pre-business combination period, we have chosen to not elect fair value option. • If a SPAC completes a business combination and we have an equity method

investment in the associated sponsor entity, the sponsor entity will record

income equal to the difference between the fair value of the restricted and

unrestricted shares we receive and the carrying value of its equity method

investment in the SPAC. We will recognize our share of this gain as income

from equity method affiliates. The sponsor entity will continue to mark its

investment in the SPAC to market after the business combination and we will

recognize our share of the change in fair value as income or loss from equity

method affiliates. Once the sponsor entity distributes our share of the SPAC

shares we owns, we will reclassify our investment from investment in equity

method affiliate to other investments, at fair value as we will hold the SPAC

shares directly (rather than through an equity method investee). We will then

record principal transactions income and loss until the SPAC shares themselves

are liquidated. • If a SPAC liquidates and we have an investment in it (either directly in the

case of consolidated sponsor entities or indirectly in the case of equity

method sponsor entities), we will write off our remaining equity method balance

and record loss on equity method investment. In the case of consolidated

sponsor entities we will also record an offsetting entry to non-controlling


  interest.






                                       72

--------------------------------------------------------------------------------

Table of Contents

Recent Accounting Pronouncements





The following is a list of recent accounting pronouncements that, we believe,
will have a continuing impact on our financial statements going forward. For a
more complete list of recent pronouncements, see note 3 to our consolidated
financial statements included in this Annual Report on Form 10-K.



In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic
740): Simplifying the Accounting for Income Taxes. This ASU is intended to
simplify accounting for income taxes. It removes specific exceptions to the
general principles in Topic 740 and amends existing guidance to improve
consistent application. This ASU is effective for fiscal years beginning after
December 15, 2020 and interim period with those fiscal years.  We are  currently
evaluating the new guidance to determine the impact it may have on its
consolidated financial statements.



In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities
(Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and
Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic
321, Topic 323, and Topic 815.  This ASU clarifies certain accounting certain
topics impacted by Topic 321 Investments-Equity Securities. These topics include
measuring equity securities using the measurement alternative, how the
measurement alternative should be applied to equity method accounting, and
certain forward contracts and purchased options which would be accounted for
under the equity method of accounting upon settlement or exercise. This ASU is
effective for public business entities for fiscal years, and interim periods
within those fiscal years, beginning after December 15, 2020. We are currently
evaluating the new guidance to determine the impact it may have on
our consolidated financial statements.



In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other
Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own
Equity (Subtopic 815-40):  Accounting for Convertible Instruments and Contracts
in an Entity's Own Equity.  This ASU simplifies accounting for convertible
instruments by removing major separation models currently required.  The ASU
removes certain settlement conditions that are required for equity contracts to
qualify for the derivative scope exception.  The ASU also simplifies the diluted
earnings per share (EPS) calculation in certain areas. This ASU is effective for
fiscal years beginning after December 15, 2023, including interim periods within
those fiscal years. We are currently evaluating the new guidance to determine
the impact it may have on our consolidated financial statements.



In October 2020, the FASB issued ASU 2020-08, Codification Improvements to
Subtopic 310-20, Receivables-Nonrefundable Fees and Other Costs.  The ASU
clarifies that an entity should reevaluate whether a callable debt security is
within the scope of ASC paragraph 310-20-35-33 for cash reporting period. This
ASU is effective for fiscal years beginning after December 15, 2021, including
interim periods within fiscal years beginning after December 15, 2022.  We
are currently evaluating the new guidance to determine the impact it may have on
our consolidated financial statements.



In October 2020, the FASB issued 2020-10 Codification Improvements.  The
ASU affects a wide variety of Topics in the Codification. The ASU, among other
things, contains amendments that improve consistency of the Codification by
including all disclosure guidance in the appropriate Disclosure Section.  Many
of the amendments arose because the FASB provided an option to give certain
information either on the face of the financial statements or in the notes to
financial statements and that option only was included in the Other Presentation
Matters Section of the Codification. The option to disclose information in the
notes to financial statements should have been codified in the Disclosure
Section as well as the Other Presentation Matters Section (or other Section of
the Codification in which the option to disclose in the notes to financial
statements appears). The amendments are effective for annual periods beginning
after December 15, 2021, and interim periods within annual periods beginning
after December 15, 2022.  We are currently evaluating the new guidance to
determine the impact it may have on our consolidated financial statements.



                                       73

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses